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Our health systems are facing an increasing number of infections involving 
antibiotic-resistant bacteria, which can no longer be treated with previously potent 
antimicrobial agents. High-throughput screening (HTS) method is widely used in 
drug discovery that allows researchers to quickly identify novel antimicrobial agents 
from various libraries of natural products or synthetic compounds. However, 
currently there are no time-saving and cost-effective high-throughput screening 
methods for discovery of antimicrobial compounds. 
In Chapter 4.1, a droplet microarray (DMA) system was established as a miniaturized 
platform for high-throughput screening of antibacterial compounds using the 
pathogen Pseudomonas aeruginosa (P. aeruginosa) as a target. Due to the 
differences in wettability of the DMA surface, it was possible to develop a rapid 
method for generating microarrays of nanoliter-sized droplets containing bacteria. A 
sandwiching method enabled immediate screening with libraries of antibiotics. A 
novel simple colorimetric readout method compatible with the nanoliter size of the 
droplets was established. Furthermore, the drug-resistance of P. aeruginosa PA49, 
an environmental isolate was investigated by using the DMA platform to screen a 
small antibiotic library.  
Subsequently, in Chapter 4.2, the work flow of HTS using DMA is optimized to adapt 
to a larger library screening. To develop new antibiotics against carbapenem-resistant 
Klebsiella pneumoniae, an important pathogen, DMA based HTS system was used 
to screen commercially unavailable compounds from the ComPlat library. The 
screening pipeline was validated, including the influence of the dispensing process 
on bacteria viability, the establishment of the colorimetric readout of screening 




antibacterial effects of compounds can be evaluated visibly by reading the color of 
droplets. Quantitative evaluation can be achieved with a cheap paper scanner. This 
research builds solid foundation for further miniaturization of HTS of compound 
libraries in order to identify novel antimicrobial substances. 
When planktonic bacteria form biofilms in the human body, persistent infections 
could be caused and become a serious problem in healthcare. Despite many decades 
of research, biofilm architecture and spreading mechanisms are still not clear partly 
due to the high heterogeneity within biofilms.  
In Chapter 4.3, patterned liquid infused surfaces (pLIS) are introduced and utilized 
to study biofilm structure of P. aeruginosa, Stenotrophomonas maltophilia, and 
Staphylococcus aureus. Biofilm patterns of different species have been formed on 
hydrophilic regions, which were separated by liquid infused borders. It is found that 
there were string-like connections between biofilm patterns, which were termed as 
‘biofilm bridges’. Fluorescence staining methods were used to investigate the 
detailed structure of bridges, showing a spatial distribution of respiratory active 
bacteria and biomass in the bridges. The core–shell structure of bridges formed by 
two-species mixed populations is illustrated.  pLIS can be useful to reveal more 
details about the fine structures within biofilm communities as well as to understand 
the spreading of biofilms and complex communication in multi-species biofilms. 
Ultimately, in Chapter 4.4, the mechanism of formation of biofilm bridges is 
illustrated. pLIS are utilized to fabricate connective structures between bacterial 
colonies of P. aeruginosa by a simple dewetting method. It is demonstrated that the 
bacteria attached to hydrophilic areas and bacteria precipitated on lubricant infused 
borders both contribute to the formation of bacterial bridges. The geometry and 
distribution of bridges can be controlled using pre designed superhydrophobic–
hydrophilic patterns. It is demonstrated that bacterial bridges connecting bacteria 
colonies act as bio-microfluidic channels and can transport liquids, nutrients, and 




bridges can be used to study formation, spreading, and development of bacterial 
colonies, and communication within and between isolated biofilms. 
Overall, this thesis shows applications of DMA in microbiology to promote the drug 
discovery, as well as to understand structures and organizations of biofilms. We 
explored the ability of DMA as a miniaturized HTS platform to identify novel 
antibiotics. This HTS system based on DMA would facilitate drug developments in 
laboratories and provide new perspectives to conduct antibacterial assays. Combined 
with lubricant infused surfaces, DMA enables fabrication of patterned biofilms. With 
a clear demonstration of structures and formation mechanism of biofilm bridges in 
this thesis, it is possible to control biofilm distribution on DMA, which will open 
opportunities to study complex architecture, heterogeneity, and interactions in 
biofilms. These results were published in three publications, while the manuscript of 






Unsere Gesundheitssysteme sind mit der zunehmenden Zahl von Infektionen mit 
antibiotikaresistenten Bakterien konfrontiert, die mit bisher wirksamen 
antimikrobiellen Mitteln nicht mehr behandelbar sind. Die Hochdurchsatz-
Screening-Methode (HTS) wird häufig in der Wirkstoffforschung eingesetzt und 
ermöglicht es Forschern, schnell neue antimikrobielle Wirkstoffe aus verschiedenen 
Bibliotheken von Naturstoffen oder synthetischen Verbindungen zu identifizieren. 
Derzeit gibt es jedoch keine zeitsparenden und kostengünstigen Hochdurchsatz-
Screening-Methoden zur Entdeckung antimikrobieller Verbindungen. 
In Kapitel 4.1 wurde ein Tröpfchen-Microarray (DMA)-System als miniaturisierte 
Plattform für das Hochdurchsatz-Screening von antibakteriellen Wirkstoffen mit dem 
Erreger Pseudomonas aeruginosa (P. aeruginosa) als Target etabliert. Aufgrund der 
unterschiedlichen Benetzbarkeit der DMA-Oberfläche war es möglich, eine schnelle 
Methode zur Erzeugung von Mikroarrays aus bakterienhaltigen Tröpfchen im 
Nanoliterbereich zu entwickeln. Eine Sandwiching-Methode ermöglichte ein 
sofortiges Screening mit Bibliotheken von Antibiotika. Es wurde eine neue einfache 
kolorimetrische Auslesemethode entwickelt, die mit der Nanolitergröße der 
Tröpfchen kompatibel ist. Darüber hinaus wurde die Arzneimittelresistenz von P. 
aeruginosa PA49, einem Umweltisolat, untersucht, indem die DMA-Plattform zum 
Screening einer kleinen Antibiotikabibliothek verwendet wurde. 
Anschließend wird in Kapitel 4.2 der Arbeitsablauf von HTS unter Verwendung von 
DMA optimiert, um sich an ein größeres Bibliotheksscreening anzupassen. Um ein 
neues Antibiotikum gegen Carbapenem-resistente Klebsiella pneumoniae, einen 
wichtigen Krankheitserreger, zu entwickeln, wurde ein DMA-basiertes HTS-System 
verwendet, um kommerziell nicht verfügbare Verbindungen aus der ComPlat-
Bibliothek zu screenen. Die Screening-Pipeline wurde validiert, einschließlich des 
Einflusses des Dosierprozesses auf die Lebensfähigkeit der Bakterien, der 
Etablierung der kolorimetrischen Anzeige der Screening-Ergebnisse und der 




antibakterielle Wirkung von Verbindungen durch Ablesen der Farbe von Tröpfchen 
sichtbar bewertet werden. Eine quantitative Auswertung kann mit einem billigen 
Papierscanner erreicht werden. Diese Forschung bildet eine solide Grundlage für die 
weitere Miniaturisierung der HTS von Verbindungsbibliotheken, um neue 
antimikrobielle Substanzen zu identifizieren. 
Wenn planktonische Bakterien im menschlichen Körper Biofilme bilden, können 
anhaltende Infektionen verursacht und zu einem ernsthaften Problem im 
Gesundheitswesen werden. Trotz jahrzehntelanger Forschung sind 
Biofilmarchitektur und Ausbreitungsmechanismen immer noch nicht klar, teilweise 
aufgrund der hohen Heterogenität innerhalb von Biofilmen. 
In Kapitel 4.3 werden gemusterte flüssige infundierte Oberflächen (pLIS) vorgestellt 
und verwendet, um die Biofilmstruktur von P. aeruginosa, Stenotrophomonas 
maltophilia und Staphylococcus aureus zu untersuchen. Biofilmmuster 
verschiedener Spezies wurden auf hydrophilen Regionen gebildet, die durch 
flüssigkeitsinfundierte Ränder getrennt waren. Es wurde festgestellt, dass es 
fadenartige Verbindungen zwischen Biofilmmustern gab, die als 
„Biofilmbrücken“ bezeichnet wurden. Mit Fluoreszenz-Färbungsmethoden wurde 
die detaillierte Struktur von Brücken untersucht, die eine räumliche Verteilung von 
atemaktiven Bakterien und Biomasse in den Brücken zeigten. Die Kern-Schale-
Struktur von Brücken, die von einer gemischten Population aus zwei Arten gebildet 
werden, wird veranschaulicht. pLIS kann nützlich sein, um mehr Details über die 
feinen Strukturen innerhalb von Biofilmgemeinschaften aufzudecken sowie die 
Ausbreitung von Biofilmen und die komplexe Kommunikation in Biofilmen 
mehrerer Arten zu verstehen. 
Schließlich wird in Kapitel 4.4 der Mechanismus der Bildung von Biofilmbrücken 
dargestellt. pLIS werden verwendet, um durch ein einfaches Entnetzungsverfahren 
Bindestrukturen zwischen Bakterienkolonien von P. aeruginosa herzustellen. Es 
wird gezeigt, dass sowohl die an hydrophilen Bereichen haftenden Bakterien als auch 
die an mit Schmiermittel infundierten Grenzen ausgefällten Bakterien zur Bildung 




durch vorgefertigte superhydrophob-hydrophile Muster gesteuert werden. Es wird 
gezeigt, dass Bakterienbrücken, die Bakterienkolonien verbinden, als bio-
mikrofluidische Kanäle wirken und Flüssigkeiten, Nährstoffe und antibakterielle 
Substanzen zwischen benachbarten Bakterienclustern transportieren können. Somit 
können Bakterienbrücken verwendet werden, um die Bildung, Ausbreitung und 
Entwicklung von Bakterienkolonien sowie die Kommunikation innerhalb und 
zwischen isolierten Biofilmen zu untersuchen . 
Insgesamt zeigt diese Dissertation Anwendungen von DMA in der Mikrobiologie zur 
Förderung der Wirkstoffforschung sowie zum Verständnis von Strukturen und 
Organisationen von Biofilmen. Wir untersuchten die Fähigkeit von DMA als 
miniaturisierte HTS-Plattform, um neuartige Antibiotika zu identifizieren. Dieses auf 
DMA basierende HTS-System würde die Arzneimittelentwicklung in Labors 
erleichtern und neue Perspektiven für die Durchführung antibakterieller HTS 
eröffnen. In Kombination mit schmiermittelinfundierten Oberflächen ermöglicht 
DMA die Herstellung gemusterter Biofilme. Mit einer klaren Demonstration der 
Strukturen und des Bildungsmechanismus von Biofilmbrücken in dieser Arbeit ist es 
möglich, die Biofilmverteilung auf DMA zu kontrollieren, was Möglichkeiten zur 
Untersuchung komplexer Architektur, Heterogenität und Wechselwirkungen in 
Biofilmen eröffnet. Diese Ergebnisse wurden in drei Publikationen veröffentlicht, 
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1.1 Miniaturized HTS of Bacteria and Biofilms  
1.1.1 The Threat of Multi-Resistant Bacteria 
Antibiotics were once considered as a ‘medical miracle’ when they saved 
innumerable lives in the 20th century. Before the commercialization of antibiotics, 
infectious diseases had been the leading cause of death in Europe. At that time, 25% 
of England’s mortality was due to infectious diseases. [4] Later, a large number of 
antibiotics including streptomycin, chloramphenicol, macrolides etc. were 
discovered during 1940-1960s, leading to the antibiotic golden age. Considering the 
rapid development of antibiotic identification, it was believed that infectious diseases 
were under perfect control and would no longer pose a threat to life. [5]  
Are things now really as people expected? Currently, in Europe, there are still nearly 
700,000 people suffering from antibiotic-resistant infections and 33,000 deaths every 
year. It was estimated that the cost for antibiotic-resistant infections is over €1.5 
billion yearly in Europe. [6] In North America, more than 2 million people are 
involved in antibiotic-resistant infections yearly and 23,000 people pass away due to 
ineffective treatments every year. [5] From 2000 to 2010, the consumption of 
antibiotics in 71 countries has increased 36%, meanwhile the antibiotics that people 
are using tend to be more and more broad-spectrum. Even with the two classes of 
last-resort antibiotics, carbapenems and polymyxins, the consumption has increased 
by 45% and 13%, respectively, which is not a good sign of control of antibiotic 
resistant infections. Today, the fact is that infectious diseases have been involved in 
about 20% of deaths globally. [7]  
Usually, the initial susceptive bacteria become resistant to antimicrobial agents in the 
following two manners including: Ⅰ. mutation and selection, ⅠⅠ. gene exchange. 
Mutated bacteria are able to eliminate the effect of antibiotics by altering antibiotic 




protein to hinder the entry of antibiotics, upregulating proteins inactivating 
antimicrobial agents etc. [8] Such mutations are selected by the pressure of 
antimicrobial agents, meaning that susceptible strains are killed by antibiotics while 
the resistant strains are able to survive and proliferate. This process is termed ‘vertical 
evolution’. [9] By gene exchange, or so-called ‘horizontal evolution’, bacteria obtain 
resistance gene materials from other bacteria even from different species by 
conjugating together using pilus, infecting with bacteriophage carrying resistance 
genes, or acquiring resistance genes spreading in environment. [9] Tens of years of 
selection with various antibiotics resulted in the appearance of multidrug-resistant 
bacteria or so called ‘superbugs’ as a severe threat to human health. Typical 
multidrug-resistant bacteria include the ‘ESKAPE’ pathogens (Enterococcus 
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, 
Pseudomonas aeruginosa, and Enterobacter spp.). [10] It has been reported that over 
15% of nosocomial infections are caused by multi-resistant pathogens, which are not 
able to be treated with most antibiotics. [11] For example, it is estimated that in Asia, 
the average prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in 
hospitals is at 67.4%. [12] Another important pathogen, carbapenem-resistant 
Enterobacteriaceae (CRE) which produces New Delhi metallo-β-lactamase reported 
in 2008, has now been detected worldwide. [13, 14]  
One direct strategy to combat multidrug-resistant bacteria is to discover new 
antibiotics. However, the last new class of antibiotics was daptomycin discovered in 
1986. For a long time no breakthrough has been made in the market of antibiotics 
(Figure 1). For example, recently marketed tedizolid, dalbavancin and ceftobiprole 
in fact belong to already known antibiotic classes of oxazolidinones, 








Figure 1. Timeline of discovery of antibiotics of different classes. [16] 
Besides scientific difficulties, the reason for slow discovery of antibiotics lies in 
financial hurdles. It has been reported that it takes more than 20 years of work and 
costs of over 2 billion dollars to discover a new drug. [17] Therefore, major 
pharmaceutical companies have stopped or drastically cut their research efforts for 
developing new antimicrobials. By not addressing this issue, even minor infections 
that are currently easily treated can become a serious health risk in the future. The 
O’Neil Report estimates that by 2050, 10 million people will die per year from 
infections caused by drug-resistant microbes. [18] The number is even higher than 
the deaths caused by COVID-19 from January, 2020 to January, 2021, which is about 





1.1.2 In Vitro Platforms for Screening of Antibacterial Agents 
The high-throughput screening (HTS) method is widely used in drug discovery as 
well as in fields of chemistry, biology, chemical biology, etc. In microbiological 
studies, HTS allows researchers to quickly identify novel antimicrobial agents from 
various libraries of natural products or synthetic compounds. [19-22] The platforms 
used in HTS play an important role, as they decide the efficiency and cost of the 
screening process. In this progress report, the state‐of‐the‐art examples of various 
platforms in HTS of antibiotics are reviewed. 
1.1.2.1 Agar Plates 
Agar plates are one of the most commonly used tools for drug-resistance test with 
bacteria. Even though the agar plate is not a preferred platform for HTS, it is 
discussed here as well, due to its importance in antibacterial assays and new 
techniques that adapt agar plates to HTS. Among various antibacterial assays on agar 
plates, the disk diffusion assay is widely applied as an official method for testing 
antimicrobial susceptibility in many laboratories. [23] Many standards based on the 
disk diffusion assay are well accepted and approved. The procedure for the disk 
diffusion assay includes inoculation of testing bacteria on agar plates with a standard 
inoculum, placement of paper disks containing antibiotics on inoculated agar plates, 
incubation and measurement of diameter of inhibition zone of bacteria growth. 
Bacteria then could be categorized as susceptible, intermediate, or resistant stain 
according to the diameter data (Figure 2). [23] The principle of the disk diffusion 
assay is that diffused antibiotics from paper disks inhibit the growth and reproduction 
of testing bacteria. Advantages of this assay include reliability, simplicity, and low 
cost.  
As a robust method, disk diffusion assay has been applied to screen antimicrobial 
susceptibility of various bacteria. [24-26] For example, Gleeson et al. screened 
susceptibility of 12 mastitis-associated bacteria to 11 commercial products for teat 




combined ingredients show better antibacterial effects than products with single 
ingredients. [27] By screening using agar plates, a new antibiotic named darobactin 
was obtained from Photorhabdus isolates (67 isolates in total) in 2019. Darobactin is 
selectively effective to Gram-negative bacteria [28]. Nevertheless, to realize high 
throughput screening with the disk diffusion assay, automation equipment is essential. 
[29] Otherwise it is time-consuming and skill-depended to obtain reliable results. 
There are other assays operated on agar plates such as antimicrobial gradient method, 
thin-layer chromatography (TLC) bioautography, agar well diffusion method, etc. 
[23] However, they have similar limitations with the disk diffusion method in HTS. 
 
Figure 2. Illustration of the disk diffussion test on agar plates. (a) Schematic illustration. (b) 
A digital image of a representative sample with inhibition zones. [30] 
In order to adapt agar plates to HTS, microwell arrays have been exploited to generate 
small compartments on agar surfaces while using each compartment as an 
independent growing area of bacteria. [31] For example, M. de Vos et al. reported a 
microbial culture chip fabricated by etching acrylic polymers on the surface of porous 
ceramic contains up to one million growth compartments. This culture chip enables 
screenings of fluorescent microcolony and galactosidase-producing microcolony on 
agar surfaces. [32] The microwell array/agar system miniaturized conventional agar 
plates by simple space separation, which is promising in future to culture bacteria on 







Figure 3. Typical microplate formats and corresponding working volumes. [33] 
1.1.2.2 Microtiter Plates 
Since the laboratory of Dr. Gyula Takatsy invented the first plate with 6 × 12 wells 
using plexiglass, microtiter plates such as 96-well plates and 384-well plates have 
been widely used in biology testing, including cell based HTS. [33-37] The design of 
plates was standardized by the Society for Biomolecular Screening together with 
American National Standards Institute (ANSI) as the SBS/ANSI standard to adapt 
plates to screening instruments and automatization. [33]  
As a conventional platform, microtiter plates have the advantage that they are 
compatible with various instruments such as liquid-moving machines, microscopes, 
microplate readers, etc. to conduct biological assays. Due to the compatibility of 
microtiter plates, different antibacterial assays such as MIC tests, ATP 
bioluminescence assays, time-kill tests, fluorescence staining, and PCR haven been 
established in wells and produced reliable outcomes. [23, 38] Therefore, the 
throughput of screening in microtiter plates has been markedly increased comparing 
to the throughput of screening with agar plates. For example, Typas et al. used 384-
well plates to conduct MIC tests to profile around 3,000 combinations of antibiotics, 
human-targeted drugs, and food additives to understand the interaction between 




Wu et al. combined HTS and drug repurposing to investigate antibacterial effect of 
2,476 FDA approved drugs. They used 96-well plates to conduct optical density 
measurement with P. aeruginosa and demonstrated that 39 drugs were able to inhibit 
growth of bacteria or formation of biofilms. [40] Chen et al. carried out antibacterial 
screening in 96-well plates after they applied sunlight-photolyzed RAFT 
polymerization to synthesize glycopolymers in wells. [41] It showed the microtiter 
plates adapt to not only biological testing but also chemical synthesizing procedures.  
Influences of parameters of microtiter plates such as surface properties, well-to-well 
contamination, microplate positional effects, etc. on drug screening have been 
discussed in another review, which provides information about correct selection of 
microplates for precise screening results. [33] As shown in Figure 3, formats 
commonly employed in most academic laboratories are 96- and 384-well plates. A 
high throughput of assays in industry can be achieved with 1,536-well plates, of 
which the working volume in each well is 3-10 µL. [42] The throughput can be 
increased further by miniaturization of wells, resulting in 2080-well plates, 3456-well 
plates, and 9600-well plates. The working volume decreases to as low as 25 nL in 
20,000-well plates. Even though working volume of microplates is reduced, working 
with miniaturized microtiter plates faces difficulties including effective mixing, 
evaporation, adhesion of liquid to the wells  ́side walls, pipetting, which need to be 






Figure 4. Microfluidic systems applied in antibacterial screening. (a) Left: Schematic 
illustration of the device to sculpt live bacteria. Right: Fluorescence images of bacteria 
growing into defined shapes. [43] (b) Schematic illustration of the ‘ichip’. Holes on the 
device are able to culture single bacteria in situ. [44] (c) Left: Schematic illustration of the 
workflow of screening of resistant mutants using droplet microfluidics. Pico droplets 
containing a mixture of bacteria suspension and antibiotics are generated in a microfluidic 
device. Droplets containing only parental antibiotic sensitive bacteria and droplets 
containing resistant mutants are detected according to their different optical densities and 
then separated. Right: A microscope image of pico droplets containing parental bacteria and 




screening. Microdroplets of known volume from four channels are generated and merged 
into microdroplets with a defined composition of bacteria suspension and antibiotics. The 
merged droplets are stored in polyethylene tubing followed by off-chip incubation. The 
metabolism of bacteria in droplets is detected by measuring intensity of reagents, such as 
resazurin in individual samples. [46] 
1.1.2.3 Microfluidics 
The past decade has seen the rapid development of microfluidics in antimicrobial 
susceptibility assays. [45, 47, 48] Two essential elements in microfluidic systems are 
channels or reservoirs of various geometries of micrometer scale and the fluids 
flowing or preserved inside channels. Microfluidic systems provide microchamber 
arrays that are capable of separating and culturing bacteria. Soft lithography with 
materials such as PDMS, hydrogel or plastic are widely used to fabricate 
microfluidics. Dekker et al. reported a high throughput device made of PDMS that 
contains 105 reservoirs in defined shapes to culture bacteria and investigated the 
oscillation patterns of Min proteins in E. coli. (Figure 4a) [43] Lewis et al. used a 
device called ‘isolation chip’, which enables culture of microbes from soil in 
millimeter-sized separated spaces, to discover a new antibiotic termed teixobactin, 
without observing resistant mutant of S. aureus or M. tuberculosis. (Figure 4b) [49] 
As a benefit of booming developments in microengineering and manufacturing, 
antibacterial screenings can be miniaturized with various microfluidic platforms, 
leading to small working volumes (nano to picolitres) and small amount of reagents 
required in screening. [50] However, to increase the throughput of antibiotic 
screening using microfluidics is still challenging. 
As a promising option, droplet microfluidics is one fascinating subset of 
microfluidics. [51] In droplet microfluidics, two immiscible phases including one 
continuous phase, which carries droplets, and one dispersed phase, which forms 
droplets, are required. Passive droplet generation strategies such as cross-flowing 
droplet formation, flow focusing droplet formation and co-flowing droplet formation 




flow rate ratio of the two phases, interfacial tension between two phases, and the 
geometry of channels. [53] Owing to the rapid droplet generation, droplet 
microfluidics has been used in HTS of antibiotic resistance studies. [53] Smith et al. 
reported a microfluidic-based pico droplet platform to create picoliter droplets of 
bacteria suspension with antibiotics and use measurement of optical density to select 
resistant strains. This high throughput assessment enables isolation of antibiotic-
resistant bacteria, for example strain HS 151 of E. coli in a label-free manner (Figure 
4a). [45] Garstecki et al. applied a multi-channel microfluidic to prepare hundreds of 
droplets containing bacteria and antibiotics over a range of concentrations precisely 
in minutes. Therefore, rapid screening of toxicity of combinations of antibiotics and 
epistatic interactions between antibiotics can be achieved (Figure 4b). [46] Even 
though droplet microfluidics enable miniaturization of rapid antibacterial screening, 
further effort should be taken to enhance its capability to screen large libraries of 
potential antimicrobial reagents. [50] 
 
Figure 5. Peptide arrays in antibacterial screening. (a) Schematic illustration of fabrication 
of peptide arrays through the SPOT method. (b) Up: Schematic illustration of quantum dots‐
labeled lipopolysaccharides (LPS). Bottom: fluorescence images of LPS binding patterns on 
the peptide arrays incubated with LPS of: left) P. aeruginosa 10 and right) E. coli O111:B4. 
[54] 
1.1.2.4 Peptide Array 
Antimicrobial peptides (AMPs) produced by immune systems of almost all classes 
of life emerged as a promising class of antibiotics. AMPs are well known for their 




‘ESKAPE’. [55] A peptide microarray refers to a collection of various amino acid 
sequences arranged in a spot array format on a solid substrate. Since a large number 
of different peptides are covalently bound to substrates in spots of relative small size, 
peptide arrays facilitate miniaturized screening of bioactivities of various peptides. 
[56]  
Most manufacturing of peptide microarray is based on the principle of solid-phase 
synthesis of peptides developed in the 1960s by R. B. Merrifield. [57] In various 
manufacturing strategies, the SPOT-synthesis became commercialized and widely 
used due to its flexibility and reliability.[58] Small droplets containing amino acid 
derivatives are printed on a functionalized porous cellulose membrane in predefined 
pattern. Thereafter droplets are absorbed by the membrane and form circular spots, 
which serve as individual reactors. Then amino acid derivatives in respective droplets 
react with functionalized substrates by activating their C-terminus while protecting 
their N-terminus. Washing step can be easily applied to remove unreacted amino 
acids and by-products. Next, the α-amino groups of immobilized amino acids are 
deprotected, and the washing step is carried out again. By repeating the steps of 
deprotecting, reacting, and washing, peptides of desired sequences can be ensured 
(Figure 5a). However, there are still drawbacks of SPOT-synthesis. [59] For example, 
the spot size achieved in most cases is 1.0 mm in diameter, leading to a limited 
peptide density on substrates (approximately 25 spots/cm2). The peptide spot is 
further miniaturized to increase peptide density by the particle-based synthesis (775 
spots/cm2) and lithographic method (106 spots/cm2). [60, 61] The lithographic 
synthesis uses light to remove photo-sensitive protecting groups from tethered 
peptides at selected positions with photomasks. The particle-based synthesis applied 
a laser printer to dispense microparticles embedded with different amino acid 
derivatives on array substrates. Recently, further improvement of fabrication of 
peptide arrays have been made. For example, a combinatorial LIFT method and 




Benefiting from developments of techniques of peptide array fabrication, the 
produced libraries have been used to screen novel AMPs. Svarovsky et al. used a 
peptide array consisting of only 10,000 random sequences to screen bacterial 
lipopolysaccharides (LPS) and investigated the binding patterns of peptides and 
bacteria (Figure 5b). [54, 56] Arya et al. have synthesized a library containing 215 
peptidic-aminosugars by solid phase synthesizing. The antibacterial effects and 
binding affinities to bacterial 16S ribosomal A-site RNA of the synthesized peptidic-
aminosugars have been screened to find potential aminoglycoside antibiotics. [64] In 
another study, a new peptide named IDR-2009 (KWRLLIRWRIQK-NH2) was 
discovered to possess enhanced antibiofilm activity against MRSA and P. aeruginosa 
based on SPOT strategy. [65] 
 
Figure 6. Examples of fabrication of patterned hydrophobic surfaces. (a) method: 
photolithography. [66] (b) method: soft-lithography. [67] (c) Method: laser ablation. [68] 
1.1.2.5 Droplet Microarray (DMA) Platform 
Since the first bio-microarray was developed by Langer et al., [69] 2D droplet 
microarrays have emerged as a versatile platform in cell-based HTS such as screening 
of single cells and 3D cell structures. [69-74] As an alternative of microtiter plates, 




to arrange a large number of droplets on solid substrates, in that case parallel reactions 
are confined to individual droplets to enable HTS. [71] Volume of droplets can be as 
low as 3 nL. [75] Owning to the open system, droplet microarrays eases the 
transferring of drug libraries in its system comparing to microfluidic systems.  
Small volume of droplets on surfaces can be created by several methods including 
contact/non-contact dispensing, dip-pen nanolithography, and liquid deposition using 
patterned hydrophilic/hydrophobic surfaces. [76] In order to screen drug libraries 
with droplet microarray, combination of functionalized surfaces such as patterned 
hydrophobic surfaces and liquid dispensers is usually required. The differences of 
wettability of patterned hydrophobic surfaces enables formation of droplets by 
sliding or dragging a bulk droplet over the surface. Meanwhile test compounds can 
be added into droplets with liquid dispensers. [76]  
Patterned hydrophobic surfaces can be achieved using photolithography, soft 
lithography, surface etching, etc. as shown in Figure 6. [74] In photolithography, a 
photomask is applied to allow or block light to control the reaction region. Therefore, 
a substrate patterned with hydrophilic or hydrophobic functional groups can be 
fabricated. Recently, our research group has developed the fabrication of droplet 
microarrays based on photolithography and demonstrated applications of droplet 
microarrays in biology assays.[77, 78] In order to prepare patterned hydrophobic 
surfaces, dendrimeric surface or porous polymer films (poly(2‐hydroxyethyl 
methacrylate‐co‐ethylene dimethacrylate), HEMA‐co‐EDMA) modified with high-
density alkene groups were applied as substrates, while hydrophilic molecule such as 
cysteamine hydrochloride or 1-thioglycerol and hydrophobic molecule 1H, 1H, 2H, 
2H‐perfluorodecanethiol (PFDT) are spatially functionalized to substrates via 
sequential UV‐induced thiol‐yne click reaction. [66, 79] In soft-lithography, PDMS 
with specific geometrical features is usually applied as templates to endow surfaces 
with hydrophilic/hydrophobic pattern. [80, 81] For example, Lee et al. used a PDMS 
master with micropatterns to stamp liquid phase paraffin on glasses, in order to 




applications. [67] Negative microcontact printing method using PDMS is 
demonstrated as well, which generates hydrophilic polydopamine (PDA) arrays on 
hydrophobic perfluorinated surfaces. [82] Surface treatments such as UV 
illumination, oxygen plasma treatment and laser ablation are widespread approaches 
to create patterned hydrophobic surfaces. For example, Dittrich et al. fabricated a 
microarray containing 2780 hydrophilic spots (720 µm center-to-center distance) 
surrounded by hydrophobic regions through laser ablation on a polysilazane-coated 
glass slide. A nanoscale liquid chromatography (nano-LC) was applied to separate a 
proteolytic digest and spotted the eluate on the prepared microarrays to screen protein 
phosphorylation. [83]  
 
Figure 7. DMA in cell-based screening. (a) Schematic illustration of a workflow of cell‐
based screening using DMA and a sandwiching method. (b) Fluorescence images of HeLa 
cells on DMA slides after a treatment with doxorubicin. Left: Samples treated with 
doxorubicin in droplets showing red fluorescence. Middle: HeLa cells stained with calcein 




Our group has developed a sandwiching method to add libraries of testing drugs into 
droplets on DMA as shown in Figure 7. [77] With optimizing the DMA platform and 
HTS working line, DMA possesses great potential as a platform in multidrug-
resistant (MDR) tests and HTS of antimicrobial compounds. Wang et al. applied a 
non-contact printer to create a lectin-hydrogel array affiniting bacteria, then 4 
antibiotics were delivered to hydrogel spots. The inhibition efficiency of antibiotics 
to S. aureus was detected. [84] However, DMA as a miniaturization platform for 
antibacterial screening with compound libraries has not been investigated in detail by 
now.  
1.1.3 Summary and Perspectives 
Here, different platforms that have been exploited to conduct antibacterial screening 
are summarized. Currently, agar plates and microtiter plates are still the most widely 
used platforms due to their simplicity and compatibility to analytical laboratory 
techniques. As robust methodologies, the two platforms are applied to develop 
standards of drug sensitivity tests such as MIC tests and inhibition zone tests.  
In order to reduce the consumption of reagents, miniaturization of antibacterial 
screening systems has been an increasing interest in recent years. A typical approach 
is to increase the density of microplates. By this manner the testing volume down to 
a few nanoliter can be achieved. Strategies based on microfluidic systems have been 
developed to screen antibacterial agents or drug-resistant mutants. Small droplets can 
be rapidly achieved using microfluidics. Nevertheless, there is still a great challenge 
to screen compound libraries with microfluidics, since automation of library addition 
into droplets is required. As an open system, peptide array has the advantage to 
combine synthesis of potential antimicrobial peptides and antibacterial screening on 
one surface. Mature techniques such as the SPOT method enable manufacturing of 





Sessile droplets have been reported as an alternative to microwell plates. Working 
with droplets possesses the following advantages: (1) cost savings due to lower 
consumption of reagents and consumables used in small volumes; (2) eliminations of 
automation in laboratories; (3) improvement of limitations present in microplates, 
such as mixing and liquid adhesion. It is now well established that droplet microarray 
can be used in screening of eukaryotic cells even to form 3D cell spheroids. However, 
few studies have investigated applications of droplet microarray in drug sensitivity 
tests of bacteria. To adapt DMA to HTS of antibacterial compounds, the following 
issues should be considered including (1) the effect of small volume and high surface-
to-volume ratio on bacteria growth in droplets; (2) the combination of compound 
libraries and droplets; (3) access of droplets for downstream analysis with existing 
techniques in microbiology. With clarification of these key points, DMA can 




1.2  Patterned Biofilms 
1.2.1 Biofilms 
As opposed to the planktonic state, bacteria in nature and industrial environments 
tend to adhere to surfaces of both synthetic and biological origin. Once bacteria 
adhere to surfaces and settle down, they will secrete extracellular polymeric 
substances (EPS) composed of polysaccharides, extracellular DNA, proteins, etc. 
Therefore, the living form of bacteria is changed from free living state to sessile 
communities (Figure 8). The adhered bacteria embedded in EPS are defined as 
biofilms, where EPS functions as ‘glue’ to maintain biofilms and possess other 
functions, for example, to protect bacteria from harsh environments. [85] Bacteria 
are different in many ways compared to planktonic ones such as metabolic activity, 
growth rate, transcriptions, and translations. [86] Bacteria in biofilms present 10-
1000 times more antibiotic resistance than planktonic bacteria. In addition to the 
resistance mechanisms of planktonic bacteria such as target site alteration, efflux 
pumps, drug modifying enzymes, low cell wall permeability, resistance mechanisms 
of biofilms also include transferring of horizontal resistance genes, impeded 
penetration of antibiotics, emergence of slowly growing subpopulations such as 
persisters and viable but nonculturable (VBNC) bacteria. [86] Therefore, biofilms are 





Figure 8. Schematic illustration of biofilm formation. [87] 
It has been reported by the National Institute of Health (NIH) that biofilms are 
involved in approximately 80% of all microbial infections in the human body. There 
are in general two types of infections caused by biofilms. One is that biofilms form 
on surfaces of medical implant devices such as catheters, artificial heart valves, 
contact lenses, joint prosthesis, dental unit, etc. The dispersed bacteria from mature 
biofilms on those surfaces have a chance to cause urinary tract and bloodstream 
infections. [88] Typical treatment for biofilm associated infections on devices is 
surgical replacement of the contaminated device, which leads to financial loss and 
secondary injury to patients. Biofilms in host tissues often cause chronic infections, 
such as chronic lung infections, chronic prostatitis, chronic otitis media, chronic 





Figure 9. Heterogeneity within biofilms. (a) Chemical gradient in biofilms. (b) Physiological 
environment in early and mature biofilms. (c) Phenotypic diversification in biofilms. Left: 
Adaption to the physiological environment of bacteria. Middle: Mutations. Right: Stochastic 
gene switching. [90] 
A major feature of biofilms is their biological heterogeneity, which means that 
bacteria of diverse phenotypes and genotypes coexist within a biofilm. Different from 
a nascent biofilm, where all cells inside are capable of obtaining substrate and oxygen 
due to rapid diffusive transport, mature biofilms possess chemical gradients inside. 
For example, cells in the upper layer of biofilms often respire oxygen actively, while 
the interior bacteria have no access to oxygen. [90] With increased depth into 
biofilms, the concentration of nutrients decreases, while the concentration of 
metabolic products of bacteria rises. For example, in biofilms of methanogenic 
bacteria, the methane concentration at the surface is only 10% of that measured in 




To adapt to diverse chemical environments in mature biofilms, even in a single-
species biofilm, bacteria could present at least three different states. Cells located at 
the interface of biofilm and fluid have access to both nutrients and oxygen, leading 
to aerobic metabolism and often rapid growth. Deeper in the area where oxygen is 
depleted, cells grow by aerobic metabolism. In the zone where both oxygen and 
nutrients are depleted, cells become inactive. There are more factors that contribute 
to the physiological heterogeneity such as different electron acceptors and donors and 
diverse metabolic capabilities of bacteria. [90] In mixed-species biofilms, there is a 
possibility for bacteria to distribute according to their species and chemical micro-
niches, due to the capability of bacteria to sense and adapt to the environment. When 
bacteria confront anaerobiosis, starvation, pH alteration, oxidative stress, and 
antimicrobial treatments, the expression of corresponding gene will be finely 
regulated. Therefore, the adaptation of bacteria to diverse chemical environments 
contributes to physiological and biological heterogeneity in biofilms.  
Genetic variation and stochastic gene expression result in genetic heterogeneity in 
biofilms. Genetic variation caused by mutation and recombination enables 
emergence of variant subpopulations. For example, Molin et al. reported mutations 
in the wapH homologue, which is associated with lipopolysaccharide biosynthesis, 
leads to a rapid evolution and better adaptability of Pseudomonas putida in a mixed 
biofilms with Acinetobacter sp. [92] In mixed-species biofilms, horizontal gene 
transfer between bacteria can be achieved by transformation, transduction or 
conjugation. The easy spread and share of resistance genes through horizontal gene 
transfer is one of the mechanisms that biofilms present high antibiotic resistance. 
Stochastic gene expression enables diverse phenotypes of bacteria in biofilms, which 
does not depend on the local environment. For example, Baty et al. demonstrated that 
even under identical chemical environments, the expression level of a chitinase gene 
(chiA) in a Pseudoalteromonas species is different. [90, 93] 
Hence, biofilms are highly heterogeneous at micrometer scale. Such heterogeneity 




such as biofilms on agar or in flasks. However, the delicate structure is critical to 
understand the structure-function relationship in biofilms. In addition, the 
heterogeneity of biofilms reduces reproducibility of biofilm-involved experiments in 
different laboratories, which leads to different experiment results in different 
conditions. Therefore, techniques enabling spatial control of biofilms are urgent to 
help make progress in understanding of the process of biofilm formation and 
spreading. [94] 
1.2.2 Strategies to Form Biofilm Patterns 
To control the biofilms spatially with high resolution is important to investigate the 
heterogeneity, architecture, functions, and collective phenomenon of biofilms on the 
micrometer scale. Therefore, reliable approaches to create biofilm patterns are 
needed. Formation of biofilms comprises five steps including reversible attachment, 
irreversible attachment, formation of micro-colonies, maturation, and dispersion. [95] 
During the initial attachment, bacteria overcome long-range repulsive forces and 
motion close to surfaces, meanwhile bacteria can still be easily removed from the 
surface by the shear force of fluid. In this process, surface property such as 
topography, roughness, charge, hydrophobicity, stiffness, etc. influence the 
attachment. [96-99] Therefore, strategies including using surfaces with various 
property to promote/inhibit bacteria attachment, different printing approaches to 
locate bacteria on preset regions on surfaces and combination of techniques from 






Figure 10. Microscope images of patterned bacteria on chemically modified surfaces. (a) 
PEG-coated glass surfaces were modified α‐D‐mannoside, a bacteria adhesin, through a 
photocleavable 2‐nitrobenzyl linker. UV light was used to remove α‐D‐mannoside to 
expose non-adhesive area to E. coli. [101] (b) Engineered E. coli expressing pMag proteins 
on their surface adhered to nMag protein modified surfaces under blue light. The bacteria 
were labeled with mCherry for imaging. [102] (c) Pseudomonas putida immobilized on 
polydopamine microarrays on a PEG coated glass surface. [103] 
1.2.2.1 Surface Guided Patterning 
By using patterned surfaces containing both bacteria-repellent regions and bacteria-
adhesive regions, spatially controlled attachment of bacteria can be obtained. 
Bacterial adhesins such as antibodies and poly‐L‐lysine have been employed to 
attract bacteria, while PEG has been used to shelter bacteria. [102, 104-106] For 
example, Wegner et al. applied photolithography to construct α -D-mannoside 
modified areas on non-fouling PEG coatings. Due to the recognition of α -D-
mannoside by FimH receptor locating on surfaces of E. coli, bacteria were patterned 
with a resolution down to 10 µm (Figure 10a). [101] With photolithography method, 
Feringa et al. used UV light to cleave fluoroquinolone antibiotic from agar surfaces 
and created bacteria-friendly area to form arrays of mixture of E. coli and 




modification of surfaces could be applied. Sletmoen et al. created micrometer size 
polydopamine (PD) patterns on PEG coated glass slides through microcontact 
printing. It was demonstrated that Pseudomonas putida KT2440 attached to strip 
shape PD regions and constrained to PD arrays after 5 min incubation with bacteria 
(Figure 10c). [103] Amphiphilic block copolymers have been patterned on 
polystyrene surfaces via UV crosslinking, leading to increased hydrophilicity of 
determined regions. Therefore, S. aureus was allowed to bind to modified hydrophilic 
areas with a resolution down to a few micrometers, while bacteria tended to form 
clusters. [108] 
Despite the versatile method by chemical modification of surfaces to form patterned 
bacteria clusters even single bacteria, it is still hard to persistently resist bacteria over 
time to mantain the spatially control of distribution of bacteria on surfaces. Inspired 
by nature, topographical features of surfaces have entered the field of vision of 
researchers. [109] Wang et al. classified ordered topographies into three groups 
according to the size of patterns and bacteria. The surfaces with pattern of size smaller 
than bacteria tend to have bactericidal effect, while surfaces with pattern size 
comparable to bacteria or larger have potential capabilities to control the attachment 
of bacteria to surfaces. [100] Aizenberg et al. employed arrays of high-aspect ratio 
(HAR) polymer posts of nanometer size to culture rod shape P. aeruginosa. They 
found that by adjusting post pitch ((0.9 - 4 µm), bacteria have altered their attachment 
from lying along the substrate to oriented to the substrate and fit into pitches. Then 
an array of standing up bacteria could be achieved (Figure 11a). [110] The same 
research group further reported that P. aeruginosa were capable of aggregating from 
a disordered state into an ordered state on the surface with arrays of orthogonal 
double-gradient nano-size posts. [109] Leng et al. fabricated honeycomb-like 
patterns on silicon wafers through deep reactive-ion etching. They found that sphere-
shape S. aureus are able to spontaneously attach to the edge of the honeycomb-like 
structure of 10 µm and form arrays. While this phenomenon did not happen with rod 





Figure 11. Bacteria pattern on nano- and micro-structured surfaces. (a) Fluorescence and 
SEM images show that rod-shape P. aeruginosa formed patterns on periodic nanostructure 
arrays of high-aspect ratio polymer posts. [110] (b) Fluorescence and SEM images show 
that sphere shape S. aureus patterned on honeycomb-like structured surfaces of silicon 
wafers, meanwhile no pattern of rod shape E. coli was observed. [111] 
 
Figure 12. Bacteria patterns on surfaces by direct printing. (a) Up: Schematic illustration of 
“Stamp-on” dip-pen nanolithography to print bacteria on functionalized substrates. Bottom: 
Fluorescence images of a pattern of individual E. coli printed with bacterial suspension of 
different bacteria density. [112] (b) Inkjet printers produced colony arrays using E. coli 




1.2.2.2 Direct Printing 
Instead of using chemically or physically modified surfaces to guide bacteria to self-
assemble into patterns, a more straightforward approach is to deposit bacteria to 
predetermined regions, which benefits the control of later biofilm formation. Various 
printing methods such as microcontact printing (μCP), inkject printing, dip-pen 
nanolithography and 3D printing have been developed to enable bacteria patterning. 
[114, 115]  
In μCP, a master polydimethylsiloxane (PDMS) stamp with relief pattern is often 
used to first impregnate with ink, followed by drying process and stamping on 
substrates to leave ink patterns. By this principle, E. coli were printed on agarose 
substrates as arrays and grew into bulk culture. [116] Whitesides et al. used agarose 
hydrogel as stamps instead of PDMS to print bacteria. The compatibility and liquid 
absorbing property of agarose facilitate the inking process. [117] The emergence of 
inkject-printing based arrangement of bacteria on surfaces overcomes the limitation 
of μCP to print multiple species bacteria. [113] A commercial ink-jet printer (HP 
Desktop 550C printer) has been used to print suspension of E. coli on agarose 
surfaces and generate complex patterns. [118] Dip-pen nanolithography, which uses 
an inked atomic force microscope (AFM) tip to create patterns on a surface, has been 
employed to generate single bacteria cell arrays on agarose surfaces (Figure 12a). In 
order to deliver large size ink materials such as bacteria, the tip was coated by 
nanostructured poly(2-methyl-2-oxazoline) (PMeOx) and combined with glycerol 
and tricine as carrier inks to keep bacteria from drying and increase the viscosity of 





Figure 13. 3D printed bacteria colonies. (a) Multiphoton lithography-based 3D printing of 
P. aeruginosa microcolonies in gelatin gel. [119] (b) Top view and side view of confocal z-
stack images of printed E. coli expressing GFP (A and B) by PμSL. Confocal z-stacks of 
printed E. coli expressing either GFP or mCherry (C and D). [120] (c) Digital photographs 
of 3D complex printed biofilms of TasA-HisTag Bacillus subtilis and inorganic NPs. Up: 
normal light. Bottom: under UV light. [121] (d) Different geometries of printed bacteria in 
Flink hydrogels (A to C). Two species including B. subtilis (green) and P. putida (blue) were 
printed into orthogonal lines (D). [122] 
Recently, three-dimensional printing (3D printing) of bacteria has become a 
promising area to control distribution of bacteria and biofilms, which meanwhile 
provides new perspectives to culture bacteria, investigate interactions in biofilms and 
use engineered biofilms as live materials (Figure 13). [122-125] In order to obtain 
3D bacterial communities, Shear et al. mixed bacteria in a warm solution containing 
gelatin, bovine serum albumin (BSA) and photosensitizer. Multiphoton lithography 
(MPL) technique was used to print the prepared gelatin gel into desired shape. By 




structure, with the viability of bacteria remained. They showed that in the 3D printed 
complex communities, antibiotic-resistant pathogen P. aeruginosa facilitates the 
survival of S. aureus during antibiotic treatments. [119] To provide a feasible and 
time-saving approach to generate 3D microbial-laden structures, Hynes et al. applied 
projection microstereolithography (PμSL) to create various 3D geometries 
containing different species. By printing engineered Caulobacter crescentus, which 
are able to bind lanthanide, into predetermined shapes, they demonstrated that such 
bacterial structure can be used to adsorpt neodymium and sense uranium in liquid. 
[120] Mannoor et al. applied a syringe extrusion-based 3D printer (Fab@Home) to 
successfully print electronic ink containing graphene nanoribbons (GNRs) and 
another bio-ink containing cyanobacterial onto pileus of mushrooms and formed 
intersected patterns. They demonstrated that the 3D printing enables generation of 
densely packed, anisotropic cyanobacterial cells on mushrooms to realize synergic 
operation. The photosynthesis of cyanobacterial could generate photocurrent 
transferred through GNRS as a power supply. [126] The research group of Anne S. 
Meyer has developed 3D biofilm printing not only with commercially available 
extrusion based 3D printers but also with printers assembled with K’NEX parts, a 
modular toy construction system. The printed E. coli were able to express a curli fiber 
protein, CsgA, to allow the formation of biofilms in later incubation after the printing 
process. [127, 128] With the same extrusion-based printing method, biofilms of 
Bacillus subtilis were directly used as ink to achieve 3D geometries showing self-
regeneration capacity, engineerable viscoelastic properties and templated assembly 
of inorganic nanoparticles via engineering of biofilms with variants of Bacillus 





Figure 14. Bacteria patterns on surfaces generated by optogenetic methods. (a) Fluorescence 
images of E. coli patterns. In E. coli, a light-activated transcriptional promoter (pDawn) was 
inserted upstream of the gene of an adhesin, Ag43. Control of attachment of E. coli was 
achieved with projected blue light. [129] (b) Up: Schematic illustration showing that 
biofilms can be functionalized by fusing sequences encoding the CsgA protein and Mfp3S-
pep, which promote bacteria attachment to surfaces and biofilm formation. Both genes are 
located downstream of the light-sensitive pDawn transcriptional promoter. Bottom: 
Patterned biofilms stained with crystal violet (left); bright field image showing mineralized 
composite (middle); bacteria in patterned biofilms showing induced fluorescence, indicating 
the bacteria were still alive. [130] (c) Fluorescent images showing the formation and 
disappearance of T shape biofilm patterns regulated by two lights. The level of c-di-GMP, 
which promotes biofilm formation, was regulated by near-infrared light and blue light. [131] 
1.2.2.3 Optogenetic Methods 
By gene manipulation, biofilm formation can be spatially and temporally controlled 
by light illumination. Riedel-Kruse et al. inserted the ribosomal binding site and the 
coding sequence of Ag43, a cell membrane protein promoting bacteria-surfaces 




regulated by blue light. Then E. coli transformed with pDawn-Ag43 construction 
formed biofilms of various patterns on polystyrene surfaces under illumination by a 
projector. The formed patterned biofilms remained stable in liquid culture medium 
over three days. [129] In another study, a high resolution of patterned biofilms 
(approximately 10 μm) was achieved by dual-color illumination of blue and near-
infrared light on P. aeruginosa to decrease or increase the level of c-di-GMP 
molecules that are critical to regulate EPS and biofilm formation. [131] As major 
biofilm protein components, which assemble into amyloid fibers on cell walls of E. 
coli, CsgA have been used to change the live state of E. coli from planktonic to 
biofilms under light by fusing sequences encoding the CsgA protein downstream of 
the light-sensitive transcriptional control element. This principle has been employed 
to pattern biofilms of E. coli onto various surfaces including textiles, plastic and mica. 
[132] Zhong et al. used E. coli engineered with CsgA–Mfp fusion proteins to have 
light-inducible biofilms, which promotes the process of hydroxyapatite 
mineralization. [130] Optogenetic approaches possess many advantages in patterning 
biofilms such as reversible and temporally control, and access to multifunction of 
patterned biofilms. Given such advances, one can have a view of a future in which 
bacteria can be integrated into various materials to enable new applications in fields 
of bio-sensors, wearable devices, live materials, etc. 
1.2.2.4 Other Methods 
Approaches to realize biofilm patterning are not limited to the above discussed 
methods. Xia et al. found that surface waves strongly affect biofilm formation. They 
applied deterministic waves and stochastic waves to generate different motion of 
fluid in bacteria suspension. Strong biofilms were observed under the wave antinodes 
while bacteria only settled but not attached to surfaces under nodal points. Therefore, 
patterned biofilms were achieved with determined wave patterns. [133] Using 
micropatterned PDMS with pillars, Mofrad et al. created patterned micro-colonies of 
S. aureus. They first cultured biofilms on top of PDMS micropillars with bacteria not 




and the pattern could be controlled by the direction of liquid retraction. They 
demonstrated that both biological activity of bacteria and wetting properties of 
PDMS contribute to biostring formation. [134] Furthermore, droplet evaporation and 
meniscus-layer-driven liquid motion were used to control bacteria assembly on 
surfaces. [135, 136] 
1.2.3 Patterned Liquid Infused Surfaces (pLISs) 
 
Figure 15. Liquid infused surfaces in biofilm patterning. (a) Three states of water droplets 
on hydrophobic surfaces. (b) Classification of LISs. [137] (c) Fluorescence images of 
biofilm patterns of various geometries formed on pLISs and biofilm bridges. [138] 
Inspired by Nepenthes pitcher plants, liquid infused surfaces have been well-known 
for their liquid-repelling property since 2011. [139] The system of LISs usually 
includes a solid substrate and a class of liquid trapped by the substrate as lubricant. 
To achieve a stable LIS, three principles should be followed: (i) the chosen lubricant 
and testing liquid should be immiscible; (ii) the lubricant should spread and wet on 
the substrate; (iii) the solid substrate should possess higher affinity with the lubricant 




properties of LISs, they have been widely used as anti-adhesive surfaces to cells, 
bacteria, and biofilms in many applications. [137, 140] 
The manufacturing techniques have been described in detail in recent reviews. [137, 
141] Neto et al. categorized LISs into three classes including: (i) LISs with lubricants 
infused within a layer of perfluorinated molecules grafted onto solid substrates, or 
LISs with covalently attached long-chain molecules to substrates, as they termed 1-
dimensional LISs; (ii) LISs with lubricants infused into nano/micro-porous structures 
by capillary action, as they termed 2-dimensional LISs; (iii) LISs with lubricants 
infused within 3D molecular networks, as termed 3-dimensional LISs (Figure 15b). 
[137] The selections of lubricants and substrates depend on the required applications. 
Lubricants of various molecular weights, vapor pressure, viscosity, refractive indexes 
are available in fabrication of LISs. [141] 
Combination of LISs and patterned surfaces leads to new surface properties and 
applications. For example, patterned LISs shows discontinues wetting property and 
have been used for patterning aqueous solutions, cells, and blood samples, and for 
directing droplets. [142, 143] Recently, Xie et al. used microcontact printing (μCP) 
to transfer dopamine droplets onto linear poly(dimethylsiloxane) grafted surfaces to 
allow patterning of polydopamine (PDA) on 1-dimensional LISs. They used the 
versatile properties of PDA to immobilize biomolecules, grow perovskite 
microcrystal and quantum dots thin films in patterned regions. [144] Our group 
applied a patterned 2D LIS with patterned hydrophilic-superhydrophobic porous 
polymer as substrates and Krytox 103, a fluorinated synthetic oil, as the lubricant to 
form arrays of biofilms. Geometries of biofilm clusters can be controlled by using 
predetermined micropatterns. [138] A new structure, termed ‘biofilm bridges’, 
connecting biofilm clusters has been discovered. Since natural biofilms possess 
various structures, for example, the string-like structure called ‘streamers’ that 
benefits the spread of biofilms in environments, this new artificial structure might 
enhance our understanding of formation and spread of biofilms. Therefore, further 




1.2.4 Summary and Perspectives 
Biofilms are an important living state of bacteria required to survive in harsh 
environments. Bacteria in biofilms possess different features compared to planktonic 
bacteria, such as high tolerance of treatments by antimicrobial agents. Chemical and 
biological heterogeneity in biofilms hamper understanding of cell signaling in 
biofilms, mechanisms of biofilm formation, drug resistance of biofilms, etc. 
Traditional studies of biofilms use bulk culture in microtiter plates or on agar plates, 
leading to possibilities of overlooking of small-scale interactions among bacteria and 
undesirable low reproducibility of experiments. The significance of biofilms has 
motivated numerous studies to develop techniques for spatial control of biofilms. 
Currently, patterned surfaces, printing methods and optogenetic methods are most 
widely used approaches to achieve patterned biofilms, with high resolution down to 
a few micrometers. Patterned biofilms can be achieved both in liquid medium and on 
agar surfaces.  
Despite the progress made in this field, there are still challenges in this research area 
that need to be overcome. Up to now, far too little attention has been paid to employ 
the patterned biofilm  created in laboratories to study diseases caused by biofilms in 
clinics. Another challenge is the integration of patterned biofilms with more functions, 
to realize applications in various fields including environmental monitoring, drug 






2 Work Objectives 
i) Droplet-microarray: a miniaturized high throughput screening platform of 
antimicrobial compounds  
Multidrug resistant bacteria have been severe threats to human health globally. 
Compared to the rapid development of drug resistance of bacteria, the discovery of 
new antimicrobial compounds is quite slow, leading to a dangerous situation in future 
that no effective treatments available to infections caused by multiresistant bacteria. 
[5] Factors that keep antibiotic discovery away from ordinary laboratories and 
pharmaceutical enterprises include the high cost of compound libraries and high-level 
requirements of equipment. Therefore, various miniaturized HTS platforms have 
been exploited by researchers, such as high-density microplates, microfluidics, 
peptide arrays, etc. [145, 146] However, there are still challenges. For example, 
automatic equipment is still essential for the screening with microplates. Few studies 
have been reported that microfluidics were used to screen big compound libraries.  
Droplet microarrays (DMA) is a promising miniaturized HTS platform in drug 
development. [75] Due to the discontinuous wetting property of the patterned 
superhydrophobic-hydrophilic surfaces of DMA, hundreds of aqueous droplets of 
nanoliter volume can be formed in seconds by sliding or dragging aqueous liquids 
across on DMA. In this way, automation of pipetting is not necessary. With about 
hundreds of reduction of testing volume compared to microplates (DMA: ~ 100 nL 
per spot, 384-well plates: ~ 40 µL per well), the cost of testing libraries would 
decrease.  
One of the work objectives of this thesis is to apply DMA in HTS of antimicrobial  
substances. The stated aim has defined the following project objectives: 




The process to generate droplets containing bacteria, growth of bacteria in 
small volume, viability of bacteria after overnight incubation should be 
investigated, to ensure the following drug susceptibility tests in droplets.  
2. Developments of approaches to transfer library compounds into droplets 
In order to use DMA for large libraries, the delivery of testing chemicals to 
droplets is a critical step. In this research, two approaches including a 
sandwiching method and direct dispensing method will be tested. Successful 
delivery of chemicals into droplets without any contamination is required. 
3. Developments of readout methods of inhibition of bacteria proliferation 
Readout methods compatible with HTS and laboratory equipment should be 
established. 
4. Application of DMA to discover novel antimicrobial compounds against 
multidrug resistant bacteria 
With validation of the DMA-based HTS working line, this platform should be 
used to identify antimicrobial substances from compound libraries to combat 
drug-resistant bacteria such as multidrug resistant P. aeruginosa and 
carbapenem resistant K. pneumoniae, which are important pathogens involved 
in infectious diseases. 
(ii) Formation of biofilm bridges with controlled geometries on patterned LISs  
Biofilms is a major living form of bacteria in nature as well as in medical 
surroundings including wound- and catheter-related infections or dental plaques. 
Biological heterogeneity is an important feature of biofilms. This heterogeneity is 
caused by many factors, such as chemical heterogeneity within biofilms, adaptation 
of bacteria to environments, mutants and genetic regulations of biofilm bacteria. [90] 
Very high heterogeneity of biofilm populations is a big hindrance in this research 
field, as spatial variations in cell behavior, cell density and gene expression often 
cause low reproducibility of experiments conducted in different laboratories. [138] 
Fine structures in biofilms are difficult to detect and investigate in bulk culture. 




formation and spreading. By now, various approaches including patterned surfaces, 
direct printing and optogenetic methods have been employed to fabricate patterned 
biofilms.  
Recently, a special structure termed ‘biofilm bridges’ has been discovered between 
biofilm arrays formed on pLISs. However, the mechanism of formation of biofilm 
bridges has not been demonstrated. Here, the aim of this research is to investigate the 
fine structure of biofilm bridges on pLIS and reveal the formation process of biofilm 
bridges. The stated aim has defined the following project objectives: 
1. Investigation of ubiquity of biofilm bridges using different Gram-positive and 
Gram-negative bacteria. 
2. Development of staining methods to observe biofilm bridges.  
3. Clarification of formation of biofilm bridges. 
4. Developments of methods to spatially control biofilm bridges on pLISs. 
  
Results and Discussion 
*This chapter and associated sections were published previously: 
Lei, W., Demir, K., Overhage, J., Grunze, M., Schwartz, T., & Levkin, P. A. (2020). 




3 Results and Discussion 








The increasing incidence of antimicrobial resistance in bacteria and the lack of new 
antibiotics that can be used to treat drug-resistant bacterial infections has become a 
major threat to human health worldwide. [147-149] The development of antibiotic 
resistance among various bacteria belonging to the “ESKAPE” group of human 
facultative pathogenic bacteria is a particular cause for concern. The ESKAPE group 
of bacteria comprises Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter 
spp., which are known causes of serious hospital-acquired infections. [148] Several 
of these clinically relevant bacteria have developed resistance to most currently 
available antibiotics. [147] It is estimated that during the last decade the direct cost 
caused by antimicrobial-resistant bacteria is €1.5 billion per year in the EU, Iceland 
and Norway. [150] Consequently, novel agents that control the growth of these 
human pathogens are urgently required. [28, 151, 152] Evaluation of the synergistic 
effects of existing drugs and investigation of the inhibitory activity of numerous 
naturally occurring compounds against pathogenic bacteria are also regarded as 
important approaches in the search for novel treatment options. 
 The currently available high-throughput screening methods based on multi-well 
microplates are time-consuming and costly, requiring expensive robotics for plate 
handling and pipetting. [153-158] Furthermore, this type of screening requires 
relatively large amounts of expensive reagents, and microtiter plates. Most antibiotic 
resistance analyses are based on defined protocols for routine testing, and the cost of 
the modifications required to screen newly identified natural compounds and 
synergistic effects with other compounds are prohibitive for many research and 
development (R&D) laboratories. 
Alternative methods have been developed for specific applications. Choi et al. 
developed a paper-based array to screen the electricity-producing bacteria. [159] In 
another study, a growth chip with a porous aluminum oxide layer containing small 
cavities was used to culture and screen microorganisms. With a cavity size of 7  7 
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µm and up to one million cavities per chip, this method offers the capacity for very 
high-throughput screening although single cavities cannot be used to assess the 
effectiveness of antimicrobial substances. [160] Despite the advantages of these 
alternative techniques, the difficulties associated with production and high cost 
remain. 
Recently, we introduced the droplet-microarray platform (DMA) with precisely 
separated superhydrophobic and hydrophilic areas. [2, 78, 161, 162] By wetting the 
DMA with aqueous solutions, we can create an array of small (90 nL), spatially 
separated droplets. These micro-reservoirs contain sufficient liquid to provide an 
appropriate environment for the growth of eukaryotic cells and prevent cross 
contamination, with the additional advantages of ease of handling and few pipetting 
steps. The DMA platform also facilitates the simultaneous analysis of a library of 
substances in parallel by sandwiching compound printed glass slides with DMA 
slides. [77] Thus, the DMA platform represents a simple, rapid, and highly cost-
effective method of screening the antibacterial effects of a variety of substances. 
Here, we present the DMA platform as a novel and cost-effective technology for 
performing miniaturized high-throughput screening of bacteria to accelerate the 
detection of antibiotic-resistant microbes in samples from patients and environments. 
In this study, we used Pseudomonas aeruginosa as a target strain since this 
opportunistic Gram-negative human facultative pathogenic bacterium is known to 
cause a plethora of hospital infections, including respiratory, urinary tract, and wound 
infections. [163, 164] Moreover, this pathogen is well-known for its high intrinsic 
resistance against a variety of different antibiotics and disinfectants. [165, 166] 
Therefore, due to the extensive use of antibiotics in hospitals, acquired multidrug-
resistance among P. aeruginosa is a major concern. [167, 168] Thus, in this study, 
we validated the DMA screening platform using clinically applied antibiotics to 
investigate the antibiotic-resistance of the multi-drug resistant P. aeruginosa PA49 
isolate. 
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3.1.2 Results and Discussion 
Growth of P. aeruginosa PAO1 GFP on DMA 
 
Figure 16. Growth of P. aeruginosa PAO1 on a DMA slide. (a) Scheme of bacteria seeding 
on DMA. (b) Photographs of droplets of water on the hydrophobic border (left) and 
hydrophilic square (right) of the DMA surface with the corresponding static water contact 
angle. (c) Digital image of DMA after droplets of BM2 medium formed. (d) Distribution of 
droplet volume on DMA slides. (e) Fluorescence images of P. aeruginosa PAO1 GFP 
incubated for 24 h on the DMA slide and in a 96-well plate. 500 μm, 1mm, 3mm are the 
edge lengths of hydrophilic squares. (f) Growth of P. aeruginosa PAO1 GFP strain in 96-
well plates and on DMA surfaces detected by measuring mean fluorescent intensity per pixel 
of cultured bacteria. All fluorescence intensity values were normalized against P. 
aeruginosa PAO1 GFP cultured for 24 in 96-well plates. (g) Bacterial density in 96-well 
plate and on DMA surfaces after incubation for 24 h. 
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A schematic representation of bacterial seeding and proliferation on DMA slides is 
shown in Figure 16a. Aqueous solutions applied onto this slide spontaneously form 
an array of separated microdroplets due to the difference in wettability of the 
hydrophilic square and the superhydrophobic borders (Figure 16b, Table S1). 1.5 mL 
of droplet of bacterial suspension was placed onto the superhydrophobic-hydrophilic 
array for 30 s before the slide was tilted to form microdroplets containing bacteria. 
Each DMA slide (7.5 × 2.5 cm) contains three microarray pattern compartments 
containing 196 hydrophilic squares (Figure 16c). With one DMA slide, 588 droplets 
in one second were formed, where each droplet representing an individual 
compartment for subsequent antimicrobial testing. 
The distributed volume of droplets on DMA slides were evaluated with a pattern size 
of 1 mm. Figure 16d shows a Gaussian distribution of the droplet volume, with the 
volumes of more than 80% of the droplets ranging from 70 nL to 130 nL. Based on 
this information, single droplets of 90 nL were used in the subsequent experiments. 
The distribution of the radius and height of the droplets were shown in Figure S1. 
Firstly, P. aeruginosa PAO1 expressing GFP (P. aeruginosa PAO1 GFP) was used 
to evaluate the growth of bacteria after seeding on DMA slides since expression of 
this protein facilitates direct microscopic monitoring of bacterial persistence or 
growth. The distribution of initial bacteria number in each droplet after seeding was 
shown in Figure S2a. There were 109 ± 54 bacteria in each droplet on average.  Figure 
S2b shows that the high humidity in the box could prevent the evaporation of droplets 
on DMA slides. The mass of droplets on DMA slides placed in air was decreased 
from 0.066 ± 0.001 g to 0.001±0.001 g in 25 min at room temperature. While the 
mass of droplets on DMA slides placed in the humidity box was decreased from 0.069 
± 0.003 g to 0.060±0.003 g in 15 min and didn’t change much in the next 2 h. The 
mass change of droplets incubated in the humidity box over 24 h at 37 ℃ was 
measured as well. It shows that more than 77% of the volume of droplets remained 
on the DMA after incubation.  
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To investigate the effect of pattern size on bacterial growth, three hydrophilic square 
pattern sides were applied to DMA slides. Bacteria on DMA slides with hydrophilic 
spots of 1 mm and 3 mm showed both bright green fluorescence after incubation for 
24 h, which was visually comparable with the fluorescence of bacteria grown in 96-
well plates (Figure 16e). Digital images of the bacterial spots were quantified for the 
fluorescence intensity using Axioplan software ImageJ. Here, the fluorescence 
intensity of all spots was normalized to the fluorescence intensity of bacteria grown 
in 96-well plates after 24 h incubation to investigate whether growth of bacteria 
would be affected in small volume. The fluorescence intensity of bacteria on DMA 
slides with hydrophilic spots of 0.5 mm was 0.35 ± 0.06 fluorescence units, which 
was much lower than the fluorescence intensity of the bacteria in 96-well plates. This 
result suggested that the small volumes of the 0.5 mm hydrophilic spots contained 
not enough cells of P. aeruginosa PAO1 for fluorescence signal evaluation. 
Therefore, the 1 mm spot patterns were used to form droplets on one DMA slide for 
further applications, rather than the 3 mm pattern for DMA production. The density 
of bacteria on the DMA slide was 1.8 × 109 ± 0.9 × 109 CFU mL-1, which was close 
to the density of bacteria (2.0 × 109 ± 0.6× 109 CFU mL-1) incubated in 96-well plates 
(Figure 16g, Table S1). Both fluorescence imaging and bacterial density results 
confirmed that the DMA slides with hydrophilic spots of 1 mm support the 
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DMA as a screening platform 
 
Figure 17. Droplet microarray as a screening platform. (a) Scheme of the sandwiching 
process for screening antibiotics. (b) Predesigned pattern of printed antibiotics on 
fluorinated glass slides. (c) Image of green fluorescence of the bacteria on DMA with 25 (5 
 5) spots treated sequentially with vancomycin (13.5 µM) or ciprofloxacin (40 µM). (d) 
Scan of fluorescence intensity across the yellow line shown in (c). (e) Image of red 
fluorescence of active bacteria on DMA with 25 (5  5) spots treated sequentially with 
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vancomycin (13.5 µM) or ciprofloxacin (40 µM), and stained with CTC using the 
sandwiching method. (f) Scan of fluorescence intensity across the yellow line shown in (e). 
(g) Digital image of DMA surface of the bacteria on DMA with 25 (5  5) spots treated 
sequentially with vancomycin (13.5 µM) or ciprofloxacin (40 µM)). The DMA slide was 
placed on black color paper. (h) Grayscale scan of the yellow line shown in (g). (i) SEM 
image of the transparent hydrophilic spots on the DMA surface in (g). (j) SEM image of 
opaque hydrophilic spots of DMA surface in (g). 
Aiming on a single step screening approach, the sandwiching process was evaluated 
using nano-liter amounts of antibiotics being transferred into individual bacterial 
droplets. Antibiotics were preprinted onto a fluorinated glass slide with the I-DOT 
instrument and then accurately placed into contact with the bacterial droplets on 
DMA slides using the CSC (Figure 17a, 17b, Figure S1). Figure 17c–h shows the 
results of the test using vancomycin at 13.5 μM (ineffective for inhibition of P. 
aeruginosa PAO1 growth) and ciprofloxacin at 40 μM (effective for inhibition of P. 
aeruginosa PAO1 growth) printed in on the DMA in a chequerboard pattern. Figure 
17c confirms the absence of cross-contamination during the sandwiching process 
between the droplets containing ciprofloxacin (no strong green fluorescence) and the 
neighboring droplets containing vancomycin (bright green fluorescence). A scan of 
the fluorescence intensity of each droplet is shown in Figure 17d. Furthermore, we 
used this sandwiching method to stain the droplets with CTC, which is converted to 
the red fluorescent molecule CTC‐formazan by metabolically active cells. A shown 
in Figure 17e and 17f, the bacteria showed bright red fluorescence in droplets 
containing vancomycin, which was not observed in droplets containing ciprofloxacin 
being directed against the sensitive strain of P. aeruginosa. The growth of bacteria 
can also be visually evaluated, with droplets containing actively dividing bacteria 
appearing opaque after drying, while the droplets without high density bacteria 
appear transparent (Figure 17g). We speculate that the difference in transparency is 
caused by the deposition of living bacteria and as well as the formation of a biofilm 
on the DMA surface since the printed vancomycin was not able to prevent the 
multiply of bacteria. Then the layer of bacteria reflects light leading to a brighter, 
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opaquer surface (Figure 17g). This hypothesis was supported by the SEM images 
shown in Figure 17i and 17j. A layer of bacteria was observed on the white spots, 
while there was no such bacterial film on the transparent spots. This visually 
detectable readout of bacterial growth on DMA surfaces has the advantage over the 
other approaches that no expensive device is required. 
 
Figure 18. Comparison of 96-well plates with DMA. (a–e) MIC of ciprofloxacin, 
ceftazidime, tobramycin, ampicillin, and tetracycline for P. aeruginosa PAO1 GFP assayed 
in 96-well plates and on DMA surfaces (DMA slides: readout by fluorescence intensity and 
the intensities were converted into OD values (Figure S2); 96-well plates: readout by OD 
measurement). All results were normalized to a blank control (0 µM in 96-well plates). (f) 
Time-course assay of the antibacterial activity of polymyxin B on P. aeruginosa PAO1 on 
DMA slides. 
As an antibiotic screening platform, the DMA should give comparable results to 
those obtained using a microtiter plate-based method. Hence, the MIC (Minimal 
Inhibition Concentration) of five antibiotics were investigated with P. aeruginosa 
PAO1 GFP assayed on DMA surfaces and in 96-well plates. The MIC is the lowest 
concentration of an antimicrobial compounds that is able to inhibit the growth of 
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bacteria in an overnight assay based on determination of the OD600 value. As shown 
in Figure 18, the MIC values of ceftazidime on DMA slides and in 96-well plates 
were both in the range of 6–60 μM. The MIC values of ciprofloxacin on DMA slides 
and in 96-well plates were both in the 0–1 μM range. The MIC value of tobramycin 
on DMA slides was in the 2–20 μM range, while the MIC was in the 0–2 μM range 
in 96-well plate, although values were consistent with the range of MIC values listed 
in EUCAST database (0–68 μM). Ampicillin and tetracycline were shown to be 
ineffective antibiotics for P. aeruginosa PAO1 in both the DMA slide and 96-well 
plate assays. The time dependence of the antimicrobial effect of polymyxin B was 
also investigated on DMA slides and in the 96-well plate. As shown in Figure 18f, 
the number of living bacteria was reduced by exposure to polymyxin B in a time-
dependent manner inactivating all bacteria on the DMA slides and in the 96-well 
plates in the first 2 h incubation. These observations confirm that the small volume 
of the droplet on a DMA slide does not influence the kinetics of the antibacterial 
effect of polymyxin B on P. aeruginosa PAO1. 
Antibiotic resistance study of P. aeruginosa PA49 on DMA slides 
As a new methodology, the DMA platform shows promising potential in facilitating 
and advancing antibiotic resistance studies of bacteria derived from patients or the 
environment. We investigated the ability of 18 antibiotics at two concentrations to 
inhibit growth of P. aeruginosa PA49 on DMA slides and in a 96-well plate as a 
proof of principle to identify antibiotic resistance. P. aeruginosa PA49 were isolated 
from clinical waste-water from the sewer close to the surgery department and from 
the clinical wastewater collection pipes in Germany. [169] Berditsch et al. reported 
that P. aeruginosa PA49 are resistant to gentamicin, ciprofloxacin, imipenem, 
ceftazidime, amikacin, azlocillin and piperacillin-tazobactam with using disk 
diffusion assay. [170] Here, a number of 18 antibiotics have been chosen of various 
categories of antibiotic; include β-lactam antibiotic (cephalosporins, ceftazidime, 
imipenem, meropenem, amoxicillin, carbenicillin, ampicillin, methicillin), quinolone 
antibiotic (ciprofloxacin), antimicrobial peptides (polymyxin B), macrolide antibiotic 
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(erythromycin), tetracycline antibiotics (tetracycline), aminoglycoside antibiotic 
(kanamycin sulfate, streptomycin, tobramycin), sulfonamides (sulfamethoxazole), 
chloramphenicol antibiotic (chloramphenicol) and combinations (piperacillin - 
tazobactam). We used the MIC concentration obtained from the EUCAST database 
of P. aeruginosa as reference (Table S2). We also tested 10-fold MIC concentrations 
to reveal the sensitivity of P. aeruginosa PA49 to these antibiotics. The antibiotics 
were transferred into P. aeruginosa PA49 droplets using the sandwiching method. 
After incubation for 24 h, the DMA slides were dried in air. Opaque spots (bacterial 
growth has not been inhibited) indicated the lack of antibiotic effectiveness, while 
transparent (bacterial growth has been inhibited) spots revealed that the antibiotic 
was effective. In 96-well plates, wells with high turbidity suggested the lack of 
antibiotic effectiveness, while low turbidity transparency suggested that the antibiotic 
was effective. All the results were read out visually. Figure 19a shows that, except 
for ceftazidime and polymyxin B, P. aeruginosa PA49 was not sensitive to the chosen 
MIC concentrations of antibiotics. However, piperacillin-tazobactam, cefotaxime, 
amoxicillin, carbenicillin, and ampicillin inhibited the growth of P. aeruginosa PA49 
at the high concentration (10× MIC). According to the universal definition of drug-
resistance, Pseudomonas bacteria are defined as multidrug-resistant bacteria if the 
strain is resistant to some of antimicrobial agents from the following four categories: 
penicillins + β-lactamase inhibitors, cephalosporins, carbapenems, and 
fluoroquinolones. [171] As shown in Figure 19b, P. aeruginosa PA49 isolated from 
waste-water was identified as a multidrug-resistant bacterial strain. 




Figure 19. Screening result of antibiotic effectiveness against P. aeruginosa PA49 on a 
DMA surface and in a 96-well plate. Two concentrations of antibiotics were tested. The MIC 
value of antibiotics was obtained from the EUCAST database. In the 96-well plate, 
antibiotics were transferred into the bacterial suspension (100 μL per well). On DMA 
surfaces, antibiotics were transferred into droplets of bacterial solution using the 
sandwiching method. Initial bacterial density: OD600 = 0.001. The bacteria were incubated 
with antibiotics for 24 h at 37℃. The antibiotic activity was evaluated by visual inspection 
of the transparency of the wells or droplets (opacity indicates live bacteria). Three 
experiments with 10 repeats (10 wells and 10 spots) of each concentration of antibiotics 
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were performed. The antibiotic was defined as effective when there were ≥ 8 wells or spots 
were transparent. S is sensitive; NS is not sensitive. 
3.1.3 Summary 
A novel platform for culturing bacteria in spatially separated micro-reservoirs filled 
with medium was established. This DMA platform can be used for screening the 
efficiency of clinically used antibiotics against bacterial pathogens. The advantages 
of the DMA platform are ease of handling, almost no pipetting steps in creating 
hundreds of micro-reservoirs, and parallel testing of chemical compounds in minute 
amounts for screening full drug libraries. This platform offers the ability to 
investigate drug-resistance of bacteria isolated from patients and the environment 
with minimal cost and effort. As a proof of principle P. aeruginosa PAO1 as well as 
the multi-drug resistant P. aeruginosa PA49 isolate could be grown successfully on 
the DMA surfaces within 24 h. Here, the different categories of antibiotics were 
applied by sandwiching a fluorinated glass slide preprinted with the drugs to the 
DMA containing bacteria using the CSC technology. The growth of the bacterial 
culture on DMA slides can be visualized by microscopy using a GFP expressing 
strain PAO1::GFP or applying a staining method. Furthermore, bacterial growth can 
be detected and evaluated by visual examination of the turbidity/transparency of the 
hydrophilic spots. In parallel and as a control, the obtained DMA screening results 
were comparable to those using a conventional 96-well plate assay against a multi-
drug resistant Pseudomonas aeruginosa strain. 
In further studies, the DMA platform will be used to identify potential natural or 
synthetic drug candidates for the treatment of bacterial infections. In extension, this 
DMA platform opens the opportunity to study synergetic effects of combinatorial 
drug treatment.  
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3.2 DMA-based HTS of a Library of 608 Compounds with 
Carbapenem-Resistant Klebsiella pneumoniae 
3.2.1 Introduction 
In Chapter 4.1, Droplet microarray (DMA) has been demonstrated as a potential 
miniaturized platform for HTS of antimicrobial compounds by our group. [1] Due to 
the discontinuous wetting probability of DMA, hundreds of aqueous droplets of 
around 100 nL can be generated in patterned hydrophilic regions by simply sliding a 
big droplet across the slide. A sandwiching method has been applied to adding 
reagents into droplets parallelly. [77] DMA platform has been used to successfully 
identify the drug resistance of P. aeruginosa PA49 by screening of a small library 
containing 18 antibiotics. [1]  
In this section, we aim to optimize the HTS working line with DMA to screen 
compounds able to inhibit growth of a very important pathogen, Klebsiella 
pneumoniae ATCC BAA-2146, a Gram-negative bacteria producing New Delhi 
metallo-β-lactamase (NDM-1) that is resistant against almost all beta-lactam 
antibiotics including the intravenous antibiotic carbapenem. K. pneumoniae ATCC 
BAA-2146 belongs to the family carbapenem-resistant Enterobacteriaceae (CRE), 
which is listed as an ‘urgent threat’ to public health in the report of Antibiotic 
Resistance Threats in The United States 2019. To treat infections caused by K. 
pneumoniae, double or triple antibiotic combinations are required. [172]  
In order to identify compounds inhibiting K. pneumoniae to provide new therapies, 
over 3,000 synthetic compounds from Compound Platform (ComPlat) are screened 
using DMA. The classes of compounds include benzofuran-2,3-diones, 2-pyrones, 5-
aminopent-2-enoates, polyamine adducts, etc. The molecular weight of most 
compounds is in a range of 157 - 502 Da. The octanol-water partition coefficients 
(log P) of most compounds are in a range of 0.01 – 6.01. Meanwhile the topological 
polar surface area (TPSA) of most compounds is lower than 90 Å2. According to the 
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druglikeness and Lipinski's rule of five (RO5), the compounds show potential 
druglikeness. 
Non-contact liquid dispensers are used to dispense bacteria suspension onto DMA 
and afterwards add compounds into droplets containing bacteria. A simple 
colorimetric readout method using Cell Counting Kit-8 is optimized with the DMA 
platform. Then the growth of bacteria in droplets on DMA after overnight culture can 
be detected by simply scanning the DMA slide in minutes with a paper scanner. The 
details of the screening process can be found in Chapter 5.3. After validation of the 




Figure 20. Schematic illustration of the workflow of HTS of antibacterial compounds using 
DMA. 
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3.2.2 Result and Discussion 
Distribution and growth of K. pneumoniae in droplets 
 
Figure 21. Distribution and growth of K. pneumoniae culture in droplets. (a) Fluorescence 
images of not printed and printed K. pneumoniae stained with LIVE/DEAD BacLightTM 
Bacterial Viability Kit. (b) Viability of not printed and printed K. pneumoniae. The ratio of 
live bacteria/dead bacteria was determined by counting the number of bacteria presenting 
red fluorescence and number of the total bacteria after LIVE/DEAD staining. (c) Bacteria 
number in droplets of 150 nL after printing, estimated by colony counting experiments. The 
horizontal black solid line shows the average number of bacteria in single droplets estimated 
according to initial bacteria density. The blue dash line shows the average number of bacteria 
in single droplets obtained from experimental data. (d) Bacteria number in droplets of 
different printing volume. (e) Bacteria number in 150 nL droplets after 18 h incubation, 
estimated by colony counting experiments. The yellow dash line shows the average number 
of bacteria in single droplets obtained from experimental data. Data were presented as mean 
± SD of three experiments with three repeats each time. 
DMA slides patterned with an array of hydrophilic spots separated with 
superhydrophobic borders have been used in this research. The DMA slides are with 
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a dimension of 7.5 × 2.5 cm containing 588 individual hydrophilic spots (1 mm side 
length of square spots). Due to the precise dimension of spots and stable borders, 
homogeneous bacterial droplet arrays can be generated by printing bacteria 
suspensions directly into each individual spot using a non-contact liquid dispenser. 
As shown in Figure 20, solutions of compounds in DMSO are firstly printed onto 
DMA slides with a liquid dispenser. Slides are dried in a desiccator overnight 
afterwards. Then 150 nL bacteria suspension of K. pneumoniae is printed onto each 
hydrophilic spot to form droplets. Bacteria are incubated with the compounds in 
droplets overnight. Then droplets are stained with Cell Counting Kit-8, which allows 
spots containing high density of live bacteria to present a visible orange color. 
Therefore, inhibition of growth of bacteria in droplets can be detected visibly. With 
a cheap paper scanner, the whole DMA slide can be scanned in a few minutes to 
further obtain the value of color depth of each droplet by data analysis.  
In order to investigate the influence of printing process on viability of K. pneumoniae 
in suspension, LIVE/DEAD assay was applied to detect any dead bacteria in droplets 
after printing, which are supposed to present red fluorescence due to stained 
propidium iodide. As shown in Figure 21a, no dead bacteria was observed either in 
initial bacteria suspension or in bacteria suspension collected from printed droplets 
on DMA. The viability of bacteria in printed droplets measured from LIVE/DEAD 
assay was 97.2 ± 0.3%, close to the viability of bacteria in initial bacteria suspension, 
which was 96.5 ± 1.6% (Figure 21b). The result indicates that the printing process 
caused no obvious destruction to bacteria. In order to investigate the number of 
bacteria in droplets, 60 droplets of bacteria suspension from three DMA slides were 
collected and a colony counting method was used to estimate bacteria number. As 
shown in Figure 21c, there were 100 to 300 bacteria in each droplet. The average 
bacteria number in droplets was 174.8± 57.8, which is close to the bacteria number 
(185.0 ± 8.6 bacteria per droplet) calculated according to the bacteria density of initial 
suspension and printing volume. This confirms that the printing process is not 
harmful to K. pneumoniae. Due to the precise printing by the liquid dispenser, 
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bacteria number in droplets could be adjusted by altering printing volume as shown 
in Figure 21d. With the colony counting method, bacteria number in droplets after 
overnight incubation was estimated. Figure 21e shows that bacteria proliferated in 
droplets and reached a high bacteria density of 6.5 ± 1.7 ×105 bacteria per droplet. 
Therefore, by printing with a liquid dispenser, droplets containing a certain number 
of live bacteria can be created. The droplets are generally homogeneous, since no 
obvious difference of bacteria number in droplets before and after incubation was 
detected. 
Colorimetric readout on DMA using Cell Counting Kit-8 
In order to read the screening result in a convenient, rapid, and cost-saving manner, 
a colorimetric readout method has been developed. Cell Counting Kit-8 solution is 
widely used in quantitation of viable cell numbers in proliferation and cytotoxicity 
assays. Water-soluble tetrazolium salts 8 in Cell Counting Kit-8 solution, as termed 
WST-8, is reduced by live cells to produce a strong orange dye. Therefore, cell 
number can be estimated by the formation of dyes and their light absorbance. [173] 
Droplets of 150 nL containing different bacteria numbers were generated on DMA. 
Then a staining solution of 100 nL was added into droplets and droplets were 
incubated for 1 h. Figure 22a and b show the scan images and corresponding color 
depth value of stained droplets. A color change of the droplets was observed, from 
bright orange to almost transparent with the decrease of bacteria number in droplets. 
The droplets containing bacteria of low density (650 bacteria per droplet), which was 
close to the density of initial bacteria suspension, can be easily distinguished from 
the droplets containing bacteria of high density, which was the same density of 
overnight cultured droplets (6.5 ± 1.7 ×105 bacteria per droplet). The detection 
limitation of growth inhibition of bacteria was 99.9%, and this method was not 
sensitive to detect very low numbers of bacteria in droplets. Figure 22c and d show 
that printed DMSO on DMA did not influence the growth of K. pneumoniae, 
indicating the use of DMSO as solvent for compounds will not cause any false 
positive result. DMSO was then applied as negative controls in the following 
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screening experiments. When 5.7 µM colistin were printed onto DMA spots, the 
growth of bacteria was inhibited with stained droplets showing no orange color. The 
color depth was down to 0.01 ± 0.02, much lower than the color depth of bank 
samples (0.27 ± 0.02) and negative controls (0.28 ± 0.02). Therefore, spots printed 
with 5.7 µM colistin were used as positive controls in the screening. The images 
showed that antibacterial screening on DMA shows the ‘Yes’ and ‘No’ of 
antibacterial effects of testing compounds, with effective compounds presenting 
almost transparent color and very low color depth value. Figure 22e shows that there 
was no contamination between droplets incubated with and without colistin. 
 
 




Figure 22. Colorimetric readout method to evaluate growth of bacteria in droplets using Cell 
Counting Kit-8. (a) Scan images of droplets containing different numbers of bacteria stained 
with Cell Counting Kit-8 solution. (b) Color depth of stained droplets shown in (a). (c) Scan 
images of droplets containing overnight incubated bacteria on DMA, which were printed 
with DMSO and colistin. (d) Color depth of stained droplets shown in (c). Data were 
presented as mean ± SD of three experiments with three repeats each time. (e) Left: A scan 
image of stained droplets containing bacteria on DMA. A checkerboard pattern of colistin 
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was printed on DMA before the printing of bacteria. Right: Color depth of droplets shown 
in the scan image.  
Influence of solubility of compounds in screening 
 
Figure 23. Scan images of stained droplets containing bacteria incubated overnight on DMA 
printed with antibiotics.  
Given that the testing compounds possess a wide range of water solubility and printed 
compounds are firstly dried out on DMA, it is necessary to ensure the hydrophobic 
antibacterial compounds can be screened with DMA platform. Four antibiotics 
ceftazidime pentahydrate (solubility: 0.028 mg mL-1, data from DrugBank Online), 
amoxicillin (solubility: 4.7 mg mL -1), chloramphenicol (solubility: 2.5 mg mL -1, data 
from DrugBank Online), and colistin sulfate (solubility: freely soluble in water, data 
from product description of Merck) were selected to investigate their antibacterial 
ability against E. coli K12. [174] Figure 23 shows that the minimum inhibition 
concentration of ceftazidime pentahydrate, amoxicillin, chloramphenicol and colistin 
sulfate measured with DMA were 1 mg ml-1, 4 mg ml-1, 8 mg ml-1 and 0.25 mg ml-1, 
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respectively, indicating that even hydrophobic compounds can be screened for their 
antibacterial property with DMA. 
Preliminary screening of 608 compounds from ComPlat 
 
Figure 24. Examples of DMA slides used in antibacterial screening of 608 compounds from 
the ComPlat library. (a) The layout of 152 compounds on a DMA slide. Each compound has 
three repeats. The distribution of compounds was shown with an example with red star mark. 
(b) A scan image of stained droplets containing bacteria incubated on DMA printed with 
compounds from the ComPlat library as shown in (a). Droplets as positive controls are 
shown in pink circles. Droplets as negative controls are shown in purple circles. (c) A scan 
image of stained droplets. Droplets showing positive results are shown in solid circles. 
Repeats of the compounds showing positive results are shown in dashed circles. Droplets 
are on 1 × 1 mm spots. 
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An example of a DMA slide in the HTS process is shown. 152 compounds from the 
ComPlat library were printed on a DMA slide. The layout of compounds is shown in 
Figure 24a. Five positive controls, five negative controls and 10 blank controls were 
set up on the slide. Three repeats of each compound are distributed to different 
regions of DMA to prevent any artifacts. Figure 24b shows the scan image of the 
DMA slide after the screening process. Droplets as positive controls were transparent, 
while negative controls and blank controls showed orange color as expected, 
suggesting the validity of the screening process using DMA. The value of color depth 
of droplets on the slide are shown in Supporting Information Figure S1. All droplets 
except for positive controls presented orange color, implying that no hits have been 
found from the screened 152 compounds.  
As shown in Figure 24 c, on another DMA slide, there were three compounds that 
presented positive results in the preliminary screening. The three compounds include 
X10219, X11896, and X16008. The structures of the three compounds are shown in 
Supporting Information Figure 2. X10219, X11896 and X16008 will be listed as 
candidates, which will be validated for their antibacterial effects in the next step after 
the screening of 3,000 compounds from ComPlat.  
3.2.3 Summary 
In this study, the work flow of HTS of antimicrobial compounds using DMA has 
been established and validated. It is demonstrated that cell printers can be applied to 
generate homogeneous droplets containing a certain number of bacteria. K. 
pneumoniae grew from ~ 170 bacteria per droplet to ~ 6 ×105 bacteria per droplet in 
droplets. A simple colorimetric readout method was developed. Droplets containing 
hit compounds, which lead to inhibition of bacteria growth, could be easily 
distinguished visibly. With an ordinary paper scanner, a DMA slide with 588 droplets 
(152 testing compounds) can be screened in several minutes to provide quantitative 
data of color depth of stained droplets. Finally, 152 compounds from the ComPlat 
library were screened using a DMA slide. 
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The aim of this project is to screen 3,000 compounds from the ComPlat library. 
Current experiments and results build a solid foundation for the next screening. The 
HTS working line developed in this research opens opportunities to identify 
antimicrobial agents from other libraries to provide new therapies to treat drug 
resistant infections.
Results and Discussion 
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Biofilms on surfaces is the predominant form of bacterial lifestyle not only in 
technical settings and nature but also in 80% of all infections in medicine. [175, 176] 
Such sessile bacterial communities work as a team through varies interaction and 
communication such as horizontal gene transfer, protein exchange and quorum 
sensing. [177, 178] Despite a lot of research, internal organizations, interactions 
within biofilms, mechanics and details behind biofilm development often remain to 
be determined. Reasons for this lie in the heterogeneity of biofilms, which leads to 
high variances in the gene expression, stress response and behavior of different 
subpopulations. [90] The lack of understanding of biofilm spreading is especially 
important in clinical settings, where the host immune system, drug administration or 
other factors can influence biofilm expansion and may result in severe conditions. 
[179, 180] Furthermore, biofilm removal or manipulation is a major cost intensive 
factor in technical systems as high consumptions of toxic biocides or mechanical 
efforts are performed to avoid biofilm formation (water condition and distribution). 
Biofilms play a significant role in medicine since high numbers of infections 
originate from biofilm contaminations, e.g., at implants. These biofilms are much 
more insensitive against antibiotics than planktonic pathogens especially in case of 
multi-resistance against antibiotic drugs. Hence, there is an urgent need to design 
models aiding us to investigate structure, interconnectivity, diversity, and dynamics 
in biofilm in a controllable way. 
Biofilms are highly heterogeneous due to their spatial partitions in larger structures 
(landscape), which leads to the inability to investigate fine structural changes of 
biofilm communities as a function of various relevant factors. Hence, fine changes, 
which are often critical in understanding structure-function relationships in biofilms, 
are often overlooked in case of such bulk analyses. In addition, every laboratory uses 
a different method for biofilm investigations, which might have a significant 
influence on biofilm behavior, e.g., medium composition, construction of flow cells, 
fluidic versus static culturing etc. Biofilm cannot be considered as a simple sum of 
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individual bacterial cells, but as a complex differentiated community with a 
heterogeneous 3D structure. [181] Biofilms represent organized communities 
encased in a matrix of extracellular polymeric substances (EPS) that hold microbial 
cells together to a surface. [182] EPS is composed mainly of biomolecules, 
exopolysaccharides, extracellular DNA (eDNA), and polypeptides that form a highly 
hydrated polar mixture that contributes to the overall structural scaffold and 
architecture of the biofilm. [181] Depending on the bacterial species or strains and 
the nutritional conditions, different biofilm phenotypes can be developed starting 
with a reversible attachment to surface, followed by irreversible colonization with 
formation of micro-colonies in EPS-matrix. Bacterial micro-colonies expand and a 
more structured phenotype with channels and voids is developed during biofilm 
maturation. Finally, bacteria disperse from biofilm structures and spread to 
downstream areas forming new biofilms. One of the special structural assemblies in 
biofilm are biofilm streamers, which occur under flow conditions along the fluidic 
direction. [183, 184] These filamentous structural streamers of e.g., Pseudomonas 
aeruginosa are networks of biofilm filaments consisting of EPS and bacteria. By 
catching cells flowing through the gaps between them, streamers are able to connect 
bacterial clusters and promote spreading of biofilm. [185] Revealing structure-
function relationship in biofilms might help us to prevent biofilm spreading and 
invasion in all kinds of medical and technical system. However, suitable assays for 
analysis of biofilm spreading are still missing.  
Bioinspired “slippery” lubricant-infused porous surfaces (LIS) have been exploited 
in various applications, including prevention of eukaryotic cell and biofilm adhesion. 
[139, 186, 187] Due to the liquid-like properties and the defect-free nature of LIS, it 
is difficult for mammalian cells and bacteria to attach onto them irreversibly. [140] It 
is reported that LIS were able to decrease the biofilm occupation on surfaces. [188-
190] Recently, we demonstrated a method to form arrays of biofilm clusters with 
defined 2D geometries by using patterned LIS. To our surprise, on lubricant-infused 
bacteria repellent regions, biofilm bridges were formed spontaneously between 
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neighboring clusters of Pseudomonas aeruginosa separated by LIS regions in the 
range of 50 to 500 μm. [138]  
Here we apply patterned LIS to create spatially separated biofilm clusters to 
investigate the phenomenon of biofilm bridging. Patterned LIS is a useful tool to 
study biofilm bridging, as it builds up physical “walls” between biofilm clusters, 
while allowing transport of signals, nutrients, and bacteria between them. We used 
both Gram-negative species including Pseudomonas aeruginosa, Stenotrophomonas 
maltophilia and Gram-positive species Staphylococcus aureus to investigate biofilm 
bridges. Fine structure of bridges and metabolic activity were studied with 
fluorescence microscopy. Fluorescence In - Situ Hybridization (FISH) demonstrated 
the structural organization of bridges consisting of two species mixed populations. 
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3.3.2 Results and Discussion 
P. aeruginosa PA49 form string-like structure on pLIS 
 
Figure 25. Biofilm bridges of P. aeruginosa PA49 on pLIS. a) Scheme of biofilm bridges 
formation of P. aeruginosa PA49 on patterned LIS. (b) Numbers of bridges and biofilm 
occupation of P. aeruginosa PA49 on patterned LIS after certain time points in bacterial 
suspension of BM2 medium. DAPI staining coverage of hydrophilic area calculated from 
fluorescence images with ImageJ software is presented as biofilm occupation. (c) Z-stack 
images of biofilm bridges. (Left: CTC staining. Middle: DAPI staining. Left: merge. For 
each image, up: cross section, corresponding line1; right: cross section, corresponding line 
2, middle: top view). Patterned LIS were incubated with P. aeruginosa PA49 for 24 h. Then 
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samples were stained with CTC (red color) and DAPI (white color). The thickness of the z-
stack is 40 μm. (d) Fluorescence microscope images of patterned LIS after deposition of 
microbeads labeled with red dye: (left) without biofilm and (right two) with P. aeruginosa 
PA49 biofilm formed during 24 h. Both samples were stained with DAPI (white color), 
followed by 10 min incubation with the microbeads (1 μm) for 10 min and washing with 
water. The scale bars: 100 μm. 
In order to investigate the phenomenon of biofilm bridges, we first formed an array 
of bacteria adhesive hydrophilic squares with side length of 350 µm separated by 200 
µm lubricant infused biofilm repellent regions. Perfluorinated polypropyleneoxide 
(Krytox GPL 103) was used as the lubricant. SEM image shows the porous structure 
of the surface (Figure S1), which is required to lock lubricant and form a stable 
lubricant layer. Water contact angles and sliding angles of patterned surfaces with 
and without lubricant were shown in Table S1. The sliding angles of lubricant infused 
surfaces were 1.6°± 0.2°, while the advancing water contact angles were 100.4°± 5° 
and receding water contact angles were 95.5°± 2°, indicating the slippery property of 
the surfaces. Patterned slides were incubated in P. aeruginosa PA49 strain 
suspension under shaking to grow biofilm clusters on hydrophilic spots (Figure 25a). 
We used 4 ,́ 6-diamidino-2-phenylindole (DAPI) to stain both intracellular DNA in 
bacteria and DNA in extracellular polymeric substances (EPS) of biofilms. The first 
biofilm bridges were observed on surfaces after 3 h incubation (Figure 25b), which 
increased up to 82.2 ± 5.4 bridges per cm2 after 6 h of incubation. Each hydrophilic 
square showed 0.24 biofilm bridges on average after 24 h incubation. The occupation 
of biofilm in hydrophilic spots increased with longer incubation time as well, from 
6.1 ± 1.6% after 1h incubation to more than 56.6 ± 16.3% of the hydrophilic area of 
each cluster after 6 h incubation. These observations suggested that the biofilms 
formed on the hydrophilic spots already after 1 h of incubation, while the first bridges 
were detected only after 3 h. String-like structure of biofilm was demonstrated before. 
Z. Jahed et al. used dewetting properties of poly (dimethyl siloxane) micropillars to 
fabricate “biostrings” of S. aureus after liquid retracting process. [134]  
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To demonstrate the scale of the bridge structure, we analyzed Z- stack images of the 
bridge of P. aeruginosa PA49 after 24 h incubation in BM2 medium. As shown in 
Figure 25c, the bridge did not attach to the substrate surface such as the biofilm grown 
in hydrophilic spots but rather formed an arc above the substrate’s plane. The distance 
between the highest part of the bridge and the substrate was 20.4 μm. This distance 
should be caused by the existence of lubricant, making the LIS plane higher than that 
of the hydrophilic area. To prove this further, we used 1 μm microbeads labeled with 
red dye to incubate with patterned LIS with and without P. aeruginosa PA49 biofilm 
formed. All samples were incubated in BM2 medium for 24 h, stained with DAPI 
and incubated with the fluorescent beads for 10 min. As shown in Figure 25d (left), 
on the patterned LIS without bacteria, the beads only aggregate in the hydrophilic 
spots, suggesting that beads tend to sediment and bind to the hydrophilic areas. Figure 
25d (right) showed that there was an overlay of beads and bridges, confirming that 
bridges were exposed to the medium enabling their interaction with the fluorescent 
beads. The specificity of this microbead attachment to biofilm and bridge structures 
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Formation of biofilm bridges by different bacteria species 
 
Figure 26. Fluorescence microscope images of biofilms of different species on patterned 
LIS. P. aeruginosa PA30, PA49, S. maltophilia, and S. aureus after 1 day incubation in BH1 
1:4 medium. Biofilms were stained with CTC for 3 h then with DAPI for 10 min before 
images were produced. Red color represents active bacteria from CTC staining and blue 
color represents DNA (external + inside of bacteria). The microscope observations were 
completed by ImageJ software. The scale bar is 200 µm. 
In order to understand whether the biofilm bridge formation is a ubiquitous 
phenomenon during biofilm growth in the bacterial world, four different bacterial 
species were selected. Two strains of P. aeruginosa, PA30 and PA49, as well as S. 
maltophilia were used as Gram-negative species, which occur in lung infection and 
urinary tract infection. [191, 192] In addition, we used S. aureus, a Gram-positive 
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pathogenic bacteria involved in broad clinical infections such as infective 
endocarditis and osteoarthritis. [193] These facultative-pathogenic bacteria are 
frequently associated with nosocomial infections and tend to form multi-resistances 
against clinically relevant antibiotics, which can hardly become medically treated in 
case of infections. [194, 195]  
After incubation with bacterial solution for 24 h, LIS samples were removed from 
the petri dishes and stained with CTC and DAPI. As shown in Figure 2, for all species 
biofilms were formed on hydrophilic areas. Actively respiring, CTC-positive bacteria 
(red fluorescence) could be observed in hydrophilic squares and only a few attached 
aggregates of bacteria were detected on hydrophobic slippery areas. The blue 
fluorescence from DAPI, staining intra- and extra-cellular DNA, was also found 
predominantly in the hydrophilic bacteria-adhesive squares with only a few biofilm 
colonies in the lubricant-infused regions. The biofilm bridges were clearly observed 
for all species under investigation (Figure 26). Biofilm bridges represented thin 
biofilm strings showing active metabolism (CTC-positive) and presence of intra and 
extra-cellular DNA (DAPI-positive) and connecting adjacent biofilm clusters formed 
in the hydrophilic squares. Interestingly, the CTC-staining of the bridges was brighter 
than that of the biofilm main clusters, indicating presence of highly active bacteria in 
the bridges. The shape of the bridges depended on the bacteria strain. For P. 
aeruginosa PA30 and PA49, the bridges were dense, uniform, with bright 
fluorescence of respiring bacteria, and total DNA, indicating a possible interaction of 
active bacteria and extracellular polymeric substances (EPS). Bridge formation by S. 
maltophilia performed differently compared to the other two bacteria types. This 
indicates that bridge formation is species dependent. 
Figure 27a shows the time-dependent formation of biofilm bridges for all species 
studied. The density of bridges for P. aeruginosa PA49 was the highest among all 
species. It was 56.9 ± 30.4 bridges per cm2 (0.2 ± 0.1 bridges per hydrophilic square), 
which is almost 4 times more than P. aeruginosa PA30 (13.2 ± 0.3 per cm2, 0.1 
bridges per a hydrophilic square) after 24 h incubation. S. maltophilia and S. aureus 
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developed only 1.7 ± 1.6 and 1.8 ± 2.2 bridges per cm2, respectively (0.01 and 0.01 
bridges per a hydrophilic square, respectively), much less than the both P. aeruginosa 
strains PA30 and PA49. The number of bridges increased for P. aeruginosa PA30 to 
43.1 ± 7.9 per cm2 after 48 h with refreshing the nutrient medium after 24 h. This 
increase was not observed with P. aeruginosa PA49 with similar experimental 
conditions. Similar results were obtained with S. maltophilia and S. aureus with an 
unchanged number of bridges after 24 h incubation. More generally, the density of 
bridges of all species did not increase significantly after 48 h incubation.  
The width of bridges ranged from a few micrometers to more than 70 µm, depending 
on the species and incubation times (Figure 27b). The width of bridges changed with 
the incubation time especially for P. aeruginosa PA49, which increased from 9.4 ± 
5.0 µm to 36.4 µm and the broadest bridges could reach 79.4 µm after 48 h incubation. 
Nevertheless, this increase did not continue in the next 24 h incubation. For P. 
aeruginosa PA30, the width of bridges increased from 8.5 ± 4.1 µm after 24 h 
incubation to the broadest 34.1 µm after 48 h incubation. There were no obvious 
changes in width of bridges for other species with time, as most were in a range of 
dimension from 2 to 20 µm. The distance between hydrophilic squares was 200 µm, 
therefore the length of bridges for all bacterial species was around 200 µm. For half 
bridges, which were connected with only one biofilm cluster, the length was shorter 
than 200 µm (Figure 27c). In some cases, biofilm bridges longer than the side-to-side 
distance between hydrophilic squares were observed. For example, connecting two 
corners from two biofilm squares diagonally resulted in bridges of around 280 µm. 
As previously described, P. aeruginosa PA49 is known to possess an increased 
biofilm formation capacity compared to P. aeruginosa PA30. [196] This higher 
biofilm forming potential could contribute to the increased bridge development 
especially during the first 24 h of incubation. Either the increase of bridge width of 
P. aeruginosa PA49 could be responsible for a possible start of biofilm spreading on 
the biofilm repellent slippery area. Bridge formation by S. maltophilia performed 
differently comparing to the other two bacteria types indicate that bridge formation 
is species dependent.  
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Figure 27. Formation of biofilm bridges for P. aeruginosa (PA30, PA49), S. maltophilia and 
S. aureus. (a) Number of bridges per area (cm2), (b) width of bridges at the middle of a 
bridge (b), and (c) length of bridges. Biofilm bridges were analyzed on patterned LIS after 
1, 2, and 3 days incubation in BHI 1:4 medium and stained with CTC and DAPI. The dotted 
line in (c) represents the closest distance between neighboring hydrophilic spots (200 µm). 
Composition and structure of biofilm bridges 
 
Figure 28. Fluorescence microscope images of bridges of P. aeruginosa PA49 after 24 h 
biofilm formation stained with CTC (metabolically active cells, red) and DAPI (DNA as 
total biomass indicator, blue). (a) Fluorescence intensity of CTC and DAPI staining of the 
line (white dot line) along a biofilm bridge connecting two biofilm clusters. (b) Images of 
the biofilm bridge after threshold adjustment. (c) Fluorescence microscope image of a 
biofilm bridge at a higher magnification showing active bacteria and extracellular structural 
DNA (top). Corresponding schematic (bottom). (d) Z-stacks images of a biofilm bridge. 
Images from left to right represent features of bridges at different Z-positions from the top 
to the bottom of the bridge. 
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To investigate the structure and composition of biofilm bridges, high magnification 
fluorescence microscopy was used. Figure 28a shows both CTC and DAPI 
fluorescence intensities plots along a single P. aeruginosa PA49 biofilm bridge 
formed after 24 h incubation. The fluorescence intensity corresponding to the 
metabolically active bacteria in the bridge (5000~6000 gray unit) was about 3 times 
higher than the fluorescence intensity of the biofilm located in the neighboring 
hydrophilic spots (1500~2000 gray unit). Interestingly, both the CTC and DAPI 
fluorescence increased not only in the bridge but also in the areas adjacent to the ends 
of bridges, where bridges attached to the main biofilm clusters (Figure 28a, b). Such 
bright fluorescence demonstrated an aggregation of actively respiring bacteria and 
eDNA in the bridge structures including the attachment points of the bridges. There 
is a clear overlap of both signals indicating the co-existence of active bacteria and 
eDNA inside the bridge. 
Figure 28c showed respiratory active bacteria were surrounded with a layer of nucleic 
acids (eDNA) as part of the EPS or non-active bacteria. Z-stacks scanning was also 
used to analyze the bridges in more detail. Figure 28d showed from the top of the 
bridge, fluorescence from DAPI staining was firstly presented, revealing that it is 
eDNA components of the EPS but not respiratory active bacteria exposed directly to 
the environment. Such a structure was described in Figure 28c. As commonly known, 
EPS plays a critical role in biofilm formation and contributes to some crucial features 
of biofilms, such as antibiotic-resistance, high tolerance of environmental stress and 
difficult eradication in biofilm bridges, EPS occurs as a protective shell for inner 
respiratory active bacteria, indicating the role of EPS is necessary for biofilm bridges 
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Biofilm bridges of mixed species 
 
Figure 29. Images of biofilm bridges of mixed species of (a) S. maltophilia and P. 
aeruginosa PA49. (b) S. maltophilia and P. aeruginosa PA30 after FISH hybridization. 
Here we used FISH analysis with the fluorescently labelled gene probes targeting 
specific sequences of the 16S rRNA of different bacteria types cultured on patterned 
LIS samples, aiming to deeper understand the composition of bridges and the spatial 
distribution of the cells in bridges. The oligo-nucleotide for S. maltophilia was 
labeled with a red fluorescence dye (ATTO550), whereas P. aeruginosa PA30 and 
PA49 were labeled with a green fluorescence dye (AT488). Although both bacterial 
species were found in the same biofilm bridge, the fluorescence images in Figure 29a, 
29b and S3 show a spatial segregation of the two different investigated bacterial 
species in the biofilm bridges. The two bacteria types in the bridges did not mix 
homogeneously but at the same time utilized this structural element of the biofilm. 
Both red and green fluorescent “strings” corresponding to each bacterial species were 
a few micrometers thick and went along the whole length of the bridge, which was 
clearly visible inside individual mixed population biofilm bridges (Figure 29). This 
observation may indicate the importance of the bridges as a functional unit of biofilm 
and shows the use of such elements by different bacterial species together, which in 
turn may be beneficial for the overall survival of biofilms. 
To the best of our knowledge, this core-shell structure was not reported before. The 
co-existence of P. aeruginosa and S. maltophilia in the biofilm bridges would be the 
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result of coaggregation interaction, which is caused by protein adhesions on bacteria 
surfaces, and other structural biofilm relevant factors. [199] The segregation and 
specific spatial organization of P. aeruginosa and S. maltophilia in the bridges are 
one of typical characteristics of co-operative interactions in multiple species biofilms, 
which is beneficial for efficient diffusion path for organic compounds such as 
nutrients and signaling molecules. [199] 
3.3.3 Summary 
With the help of micro-cluster analyses being fundamental to study biofilm structures 
and stimuli dependent reactions of biofilms. It was possible to describe a novel 
important phenomenon: the biofilm bridging. This biofilm bridging might have 
implications in biofilm development, spreading and surpassing adverse surface 
conditions. It was shown that this bridge strucutre is common to different Gram-
negative and Gram-positive bacteria in species-dependent manner. Organisms’ 
distribution and organization in bridges of multi-species biofilm were demonstrated. 
Hence, the biofilm bridges are important to bring deeper understanding of biofilm 
complex 3D structure. By manipulating incubation environment, formation of 
networks composed of bridges between biofilm clusters and spreading over multiple 
biofilm clusters were discovered. Thus, biofilm bridge formation is an important 
novel phenomenon, which can be useful to reveal more details about the dynamics 
and communication within biofilm communities as well as to understand the relations 
of subpopulations, stress responses including virulence regulations and biofilm 
spreading.
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Gram-negative bacteria such as Acinetobacter spp., Pseudomonas aeruginosa, 
Escherichia coli, Enterobacter spp. widely spread in natural and artificial 
environments. [200] The facultative pathogenic Pseudomonas aeruginosa is a major 
cause of chronic infections strongly involved in cystic fibrosis patients and 
immunocompromised individuals. [201] Various mechanisms including active efflux 
of antibiotics in bacteria, membrane permeability barrier, enzymatic 
inactivation/modification of drugs, and/or antibiotic target changes/protection 
contribute to the high resistance of gram-negative bacteria. [8, 202, 203] Except for 
its high level of intrinsic resistance, Gram-negative bacteria such as P. aeruginosa 
are able to achieve adaptive antibiotic resistance by living together as biofilms. [204]  
Bridge or string-like structures of bacteria colonies were reported in biofilm studies 
previously. Thus, Jahed et al. used used micropatterned poly(dimethyl siloxane) 
(PDMS) to form 3D nanostring of microcolonies of Staphylococcus aureus.[134] 
Drescher et al. demonstrated that Pseudomonas aeruginosa flowing through 
microfluidic channels made from PDMS form streamer structure, causing clogging. 
[185] In our previous study, we used patterned liquid-infused surfaces (LIS) to form 
arrays of homogeneous biofilm microclusters and observed string-like connections 
between biofilm patches. [205] Since the string-like structure is observed under 
highly controlled conditions, it indicates that this phenomenon might be common in 
nature. The phenomenon of bacterial bridges could help better understand biofilms, 
complex 3D biofilm structures, functions, or factors that can affect biofilm formation, 
and the removal of biofilms. It is not clear, how far micro-structures contribute to the 
formation and adaptation of biofilms. 
Bioinspired liquid-infused surfaces (LIS) have been introduced as an antifouling 
material. [141, 186, 206-211] The solid porous surface of LIS provides its mechanical 
stability and also stabilizes impregnating oil or lubricant. [139] Due to the liquid 
nature and smoothness of the liquid-liquid interface at the LIS’ surface, bacteria 
cannot strongly and irreversibly attach to it. [188, 212]  
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In previous study, detailed structure of biofilm bridges of P. aeruginosa was 
investigated and we showed a spatial distribution of bacteria and biomass in the 
bridges. [2] It was proposed that the biofilm bridges formed due to the migration or 
growth of bacteria on the hydrophobic repellent LIS regions. Nevertheless, the 
mechanism of the bridge formation was not known. 
In this study, the pLIS are used to investigate the mechanism of biofilm bridge 
formation of P. aeruginosa. We hypothesize that with the correct understanding of 
the formation of biofilm bridges, we could control the geometry and distribution of 
bridges by using preset hydrophilic-superhydrophobic patterns. Such controlled 
biofilm bridge formation and structuring could be used to understand the biofilm 
formation and function both in vitro and in vivo. Potentially such bridges could be 
used for bio-microfluidic applications to study the transfer phenomena through the 
bridges or in biofilm-involved infections. 




Figure 30. Bacterial bridges form during the dewetting process. (a) Schematic showing the 
bridge formation during the dewetting process on patterned LIS. (b) Formation of bridges 
between P. aeruginosa PA49 attached to hydrophilic spots over lubricant infused borders. 
3D filamentous structure of P. aeruginosa PA49 in suspension is marked with “a” and “b” 
in white. The bridges formed are marked with “a” and “b” in yellow. (c) Formation of 
bridges between E. coli attached to hydrophilic spots over lubricant infused borders. Bridges 
formed in the area indicated by yellow dashed lines. The bridges formed are marked with 
“c” in yellow. Direction of liquid retraction from the surface was indicated by black arrows. 
3.4.2 Results and Discussion 
Formation of biofilm bridges of P. aeruginosa and E. coli on pLIS 
Patterned superhydrophobic–hydrophilic glass slides were used to prepare patterned 
LIS. The patterned glass slides were firstly immersed into water to form water 
droplets on hydrophilic spots, and then perfluoropolyether (Krytox GPL 103) was 
used to spread on the surface to form the lubricant infused borders between the water 
occupied hydrophilic spots. The excess of the lubricant was removed by dipping the 
slides into water and flushing the slides with a stream of water until all hydrophilic 
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spots were exposed to air. The porous structure of the surface, water contact angles 
and sliding angles of the patterned LIS have been shown in a previous study. [2] 
Multidrug resistant P. aeruginosa PA49 previously isolated from wastewater and 
E.coli DSM1116 were used in this research. [169] Table S1 shows the height of LIS 
borders is around 10 µm. Previously we showed that string-like biofilm structures 
were observed between P. aeruginosa PA49 attached hydrophilic spots after 3 h 
incubation in bacteria suspension (Basal Medium 2, BM2). Therefore, incubated 
surfaces for 3 h were used in this study instead of 24 h. [2] As shown in Figure 30a, 
there are three steps to achieve bridges on patterned LIS. Firstly, the surfaces were 
incubated in bacteria suspension for 3 h at 37℃ with gentle shaking. During this 3 h, 
bacteria attached onto the hydrophilic spots. At the same time, bacteria precipitated 
onto the lubricant infused areas, but they were not able to attached to the lubricant 
infused borders due to their antifouling property (Figure 30a step 1). Next, the 
bacteria suspension was aspirated using a peristaltic pump, resulting in the dewetting 
of the liquid from the LIS areas exposing them to air and at the same time leading to 
the formation of biofilm bridges connecting bacteria clusters formed in the 
hydrophilic (adhesive) regions (Figure 30a step 2). Surprisingly, after the supernatant 
with bacterial suspension was completely gone, bridges remained on the lubricant 
infused borders (Figure 30a step 3). 
Figure 30b and Video S1 show the bridge formation of P. aeruginosa PA49 on the 
surfaces. On the surface incubated with P. aeruginosa PA49 for 3 h, the precipitated 
bacteria layer was found to be heterogeneous with not only small bacterial clusters 
randomly growing on the surface, but also revealing 3D filamentous bacteria 
structures stemming from the surface into bacteria suspension (Figure S1, Figure 30b, 
white a and b). Some of these filamentous structures remained on the surface during 
the dewetting process, forming bridges (Figure 30b, marked with yellow color a and 
b). After the bridge formed, a needle was used to break the bridge. As shown in Figure 
S2a and Video S3, the precipitated bacteria in the bridge were not attached to the LIS 
border, since the broken bridge shrank towards the hydrophilic area but not remained 
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still on the LIS border. Figure S2b and Video S4 show that the bridge was not 
attached to the LIS border after 24 h incubation in air. 
E. coli was used in order to investigate the formation of the bacterial bridges using 
other Gram-negative bacteria. E. coli formed a more homogeneous layer on the 
surface after incubation (Figure 30c, Video S2). When the bacteria suspension was 
removed, bacteria attached on the hydrophilic squares remained and the bacteria 
precipitating on the lubricant infused borders were removed, with some of the 
bacteria left on the surface to form bridges. Even though the precipitated P. 
aeruginosa and E. coli layers showed different structure and morphology, bridges 
formed in both cases during the dewetting procedure.  
Figure S2a shows that the bacteria number of initial P. aeruginosa PA49 suspension 
was 4.5×107 CFU mL-1. The bacteria number of the supernatant of the bacteria 
suspension after 3 h incubation decreased to 0.7×107 CFU mL-1. After mixing the 
medium above the surface, the bacteria number of the suspension increased to 3.8×
107 CFU mL-1. This indicates that a large number of bacteria precipitated on the 
surface during 3 h incubation. Interestingly, as shown in Figure S2b, there were no 
bridges formed when the surfaces were incubated vertically in bacteria suspension. 
It only showed attached bacteria on hydrophilic spots. This suggests that there are 
two requirements to form bacterial bridges. First, the surface should provide 
attachable regions for bacteria. Only with LIS itself no bridge could be formed due 
to its antifouling property. [188] The second requirement is that a certain number of 
bacteria precipitating on the surfaces is necessary to form bridges. Thus, the 
formation of biofilm bridges seems to be a consequence of the dewetting process on 
patterned LIS covered with attached and precipitated bacteria and not due to the 
growth of biofilm bridges between adhesive clusters as was hypothesized in our 
previous study. [2]  
To understand better the biofilm bridge formation and function, it is important to 
investigate factors that influence its formation. Thus, we studied how nutrients 
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present in the bacterial growth medium influence the bridge formation. As shown in 
Figure S3, no bridge was formed on the surfaces incubated in glucose-free medium, 
while only few bacteria colonies were observed on the hydrophilic spots. Glucose is 
important to form extracellular polymeric substances (EPS). [213, 214] Absence of 
glucose in the medium could affect the filamentous bacteria structures as shown in 
Figure S3c, leading to less bridge formation. There was no significant difference in 
the bridge number on the surfaces between samples incubated with or without DNase 
despite that secreted nucleic acids have been found inside biofilm bridges.[2] With 
lower bacteria density of the initial cell suspension (106 CFU mL-1) no bridges were 
formed (Figure S3). Thus, it seems that the density of P. aeruginosa bacteria at the 
interface increased by precipitation or because of the initial high concentration 
increases the ability of bacteria to form such bridges. As we discussed, bacteria 
attached to hydrophilic areas and precipitated on the surface both contribute to the 
formation of bridges, thus, we assumed that a certain number of bacteria are required 
from the initial bacteria suspension to form bridges. 
Distance-depended formation of bridges on pLIS 
In order to investigate the distance-dependent formation of P. aeruginosa PA49 
bridges, we cultured bacteria on patterned LIS with variable widths of the lubricant 
infused regions from 50 µm up to 1 mm keeping the hydrophilic adhesive spots 
identical (350 µm). Examples of biofilm bridges of up to 700 µm long can be seen 
(Figure 31), however the number of bridges per square drops significantly from about 
one bridge per biofilm spot for 50 µm gaps down to about 1 bridge per 20 hydrophilic 
spots for 700 µm gaps (Figure 31f). With 350 µm hydrophilic spots, 700 µm lubricant 
infused borders is the limit for the formation of bridges using P. aeruginosa PA49. 
In case of hydrophilic squares (length of square edge = 50, 200, 350, 500 µm) 
separated by lubricant infused borders of a constant width (200 µm), the bridge 
number increased from 0.1 per square to 0.7 per square with the increase of the size 
of hydrophilic squares. Therefore, bridges tend to form over short lubricant infused 
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border with large adhesive areas. This can be useful for predicting the bridge 
distribution on patterned surfaces. 
 
Figure 31. (a-e) Fluorescence images of CTC stained bridges of P. aeruginosa PA49 over 
lubricant infused borders of various widths (from 50 µm up to 1 mm). Side length of 
hydrophilic bacteria adhesive squares is 350 µm (indicated by white dashed lines). CTC was 
added into bacteria suspension from the beginning of the incubation. Images were taken 
after the medium was removed from the surfaces and bridges were formed due to the 
dewetting of lubricant infused regions. (f) Number of bridges of P. aeruginosa PA49 over 
lubricant infused borders of different widths. Side length of the hydrophilic square is 350 
µm. (g) Number of bridges of P. aeruginosa PA49 on surfaces with hydrophilic squares of 
different sizes, while keeping the width of lubricant infused borders the same (200 µm). 
Data were presented as mean ± SD of three experiments with three repeats each time. The 
statistical significance of the experimental data was determined with a two‐tailed Student t 
‐test (* p ‐value < 0.05, ** p ‐value < 0.001). 
 




Control of bridge pattern 
 
Figure 32. Creating biofilm bridge micropatterns of defined geometry. Fluorescence images 
of CTC stained bacterial bridges formed by P. aeruginosa PA49 on surfaces with 
predesigned hydrophilic-LIS patterns. Hydrophilic spots are indicated by white dashed lines. 
CTC was added into bacteria suspension from the beginning of the incubation to facilitate 
imaging. Images were taken after the medium was removed from the surfaces. White arrows 
in (a) and (b) indicate the direction of liquid retraction from the surface. Scale bars: 500 µm. 
Understanding the mechanism of the formation of biofilm bridges using the geometry 
of patterned hydrophilic-LIS structures allows us to create complex interconnected 
structures of biofilm bridges (Figure 32). Since discontinuous dewetting of patterned 
hydrophilic-LIS surfaces covered with a preincubated layer of bacteria is responsible 
for the formation of biofilm bridges between the adhesive regions, positioning 
hydrophilic spots closer to each other enables preferential bridge formation between 
these structures during the dewetting process (Figure 32a). In addition, since 
direction of liquid retraction is important for the dewetting process, it could be used 
to align biofilm bridges to form networks of biofilm bridges with aligned parallel 
lines along different directions (Figure 32). Figures 32c-f demonstrate the possibility 
to create single biofilm bridge lines of defined geometry by positioning multiple 
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hydrophilic spots into a certain pattern on a lubricant infused background. Such 
architectures might be useful to study biofilm organization and various signaling or 
transport phenomena within biofilms.  
Bacterial bridges as bio-microfluidic channels 
In order to investigate continuity of the biofilm bridges, we utilized 1 mm hydrophilic 
spots (square side length 1 mm, lubricant infused border between squares 500 µm) 
(Figure 33a). Bacterial bridges were formed by the incubation of patterned LIS with 
P. aeruginosa PA49 for 3 h, followed by removing the medium to form the bridges 
and either leaving the structures under air (Figure 33b, c) or covering the biofilm 
bridges with a fluorinated lubricant (Figure 33d, e). 1 µL Rhodamine B solution was 
added to the first hydrophilic spot (spot 1) and the spreading of the dye solution 
through the bridges was monitored over time (Figure 33c). Figures clearly 
demonstrate that the dye is spread through the bridges and does not escape from the 
bridges  ́walls. No fluorescence was observed on the lubricant infused surface outside 
the bridge structures. This suggests strong hydrophilicity of the bridges and their 
confinement. The dye reached spot 2 and 3 within a few seconds and covered spot 3 
within 2 min. Then the spreading of the dye slowed down and it was observed in spot 
4 only after 1 h (Figure 33c). The mechanism of spreading in this case is related to 
wetting of the hydrophilic bridges with the aqueous dye solution. Then, we also 
investigated the diffusion of the dye through the bridges confined under an oil. In this 
case, a layer of lubricant was spread to cover the bacterial bridges as well as biofilm 
clusters attached to the hydrophilic squares, while keeping one hydrophilic spot 
exposed to air to be able to add the dye solution (Figure 33d). In this case, the 
spreading of the dye was significantly slower than in the open system and the dye 
took 2 h and 24 h to reach and cover spots 2 and 3, respectively. Nevertheless, the 
spreading clearly demonstrated the continuity of the biofilm bridges connecting 
hydrophilic spots indicating its potential application to study various transfer 
phenomena through the bridges or bridges  ́functionality in vivo. The average width 
of the bacterial bridges was 99.4 µm while the smallest width was 18.4 µm (Figure 
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S4). These microchannels are composed of biomass and bacteria from the bacteria 
suspension, which makes them fully biological microfluidic channels (bio-
microfluidic channels). Here we define “bio-microfluidic channels” as 
microstructures made of bacterial colonies, which are able to transport fluids. 
 
Figure 33. Flow of rhodamine B solution through bridges. (a) Bright field image of P. 
aeruginosa PA49 on hydrophilic spots after the bacteria suspension was removed. (b) 
Schematic representation of addition of rhodamine B solution on hydrophilic spots. The 
surface was exposed to air. (c) Snapshot images at different time points showing the transfer 
of rhodamine B solution (water, 2 mg mL-1) through the bridge of P. aeruginosa PA49. (d) 
Schematic representation of addition of rhodamine B solution on hydrophilic spots. 
Rhodamine solution was added on one hydrophilic spot with P. aeruginosa PA49 which 
was exposed to the air. The other area around this spot was covered with lubricant. (e) 
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Diffusion of rhodamine B solution (water, 2 mg mL-1) under lubricant through a biofilm 
bridge of P. aeruginosa PA49. Time format shown in all images (hh:mm:ss). 
To further demonstrate the connectivity of bacterial bridges as bio-microfluidics, we 
used brain heart infusion medium (BHI medium) as nutrient-rich medium and 
polymyxin B as effective antibiotic to P. aeruginosa PA49 and evaluated their 
influence on bacteria viability after the transfer through bridges as shown in Figure 
34a. [170] Water was used as control. Figure 34b shows that the number of living 
bacteria in spot 3 was influenced by the chemical added in spot 1, which demonstrates 
that the chemical solution was successfully transferred from spot 1 to spot 3 through 
bridges. With BHI medium added in spot 1, the number of living bacteria in spot 3 
was 11.3×107 CFU mL-1, twice as much as the number of living bacteria in spot 3 
when water was added in spot 1. No living bacteria were in spot 3 with polymyxin B 
added in spot 1. However, there was no significant difference of the number of living 
bacteria in disconnected spot 3’, when different chemicals were added in spot 1’, 
suggesting that the solution did not spread to other spots on the surface without 
bridges. Therefore, the bridges have good connectivity to function as bio-
microfluidics. Such bio-microfluidics could be used to study the biofilm formation, 
heterogeneous structure of biofilms and the spatial variation associated cell behavior. 
[90, 181, 215] Comparing to the conventional microfluidic system using solid 
material to fabricate channels, the bio-fluidic channels made of bacterial bridges have 
the advantage to study bacteria behavior not only on solid-liquid interfaces but also 
on liquid-liquid interfaces. And it is an open system with no solid boundary. [135, 
216] P. aeruginosa PA49 used to form bridges is a multidrug-resistant species. [1] 
Therefore, the bio-fluidic channels can be used to study the drug susceptibility of 
bacteria/biofilms. In addition, there are biofilm niches in the human body such as 
biofilm niches in oral cavity and in pulmonary alveoli, which are physically separated, 
but able to affect each other. [217, 218] With the bridge-formed bio-microfluidic 
systems, it is possible to study such systems in-vitro, for example, the influence of 
anti-biofilm compounds on heterogeneous biofilms or the transfer of signals, 
nutrients between biofilms communities. 




Figure 34. Schematic representation of experiment to study connectivity of the bridges. Side 
length of hydrophilic spots: 1 mm; lubricant-infused borders: 500 µm wide. Surface was 
kept under air after the dewetting step of the biofilm bridge formation. 1 µL water, BHI 
medium or polymyxin B (50 mg mL-1) was added on the hydrophilic spot 1 with P. 
aeruginosa PA49, respectively. (b) The number of bacteria was measured either in the 
connected spot 3 or disconnected spot 3’ 2 h post addition of the solutions to spots 1 or 1´, 
respectively. Data were presented as mean ± SD of three experiments with three repeats each 
time. 
3.4.3 Summary 
Fine control of organization of bacteria or biofilms on surfaces provides great 
opportunity to study biofilm formation, spreading mechanism or signal exchange 
between different biofilm colonies. Here we present a strategy to create connective 
bridge structure between bacterial colonies with defined geometry using patterned 
lubricant-infused surfaces (pLIS) in a simple dewetting process. We demonstrate that 
after incubation with bacterial suspensions, bacteria cover the whole surface 
including lubricant infused borders. During the growth medium removal, 
discontinuous dewetting leads to the formation of biofilm bridges connecting 
hydrophilic adhesive hydrophilic spots with irreversibly attached bacterial colonies. 
The width of lubricant infused borders affects the bridge formation. We demonstrate 
the possibility to control spatial distribution of bridges by using specific patterns of 
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hydrophilic spots. Finally, the ability to transfer liquids and dissolved chemicals 
along the biofilm bridge networks has been demonstrated, which opens a new 
possibility to investigate the transfer of signals, nutrients, or small molecules through 
such biofilm structures. Biofilm structures with defined geometry can be used as bio-
microfluidic channels to study the fundamental biofilm functionality, the transfer 
dynamics of pharmaceuticals in medically relevant infectious biofilms or in technical 
setups where signaling processes impact the stability and function of natural biofilms.  
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4 Conclusions and Outlook 
Within this thesis, droplet-microarray has been applied to solve problems in 
microbiology, especially in the field of combating multidrug-resistant bacteria. The 
content of this thesis can be subdivided into two parts:  
1) Droplet-microarray was applied as a miniaturized platform of high throughput 
screening of antimicrobial compounds;  
2) Droplet-microarray was used to fabricate patterned liquid infused surfaces to 
reveal the mechanism of biofilm bridge formation and to spatially control formation 
of biofilm bridges. 
Currently, most conventional platforms of high throughput screening of antimicrobial 
substances require expensive automation. The high cost of compounds or drug 
libraries hinders laboratories to investigate new antibacterial agents in a high 
throughput manner. As a miniaturized high throughput screening platform, droplet-
microarray possesses many advantages, including ease of handling, fewer pipetting 
steps are required, and reduction of reagents. In the first project, an easy and rapid 
‘droplet sliding’ method was used to generate 588 droplets of ~100 nL in seconds 
containing bacteria, as a benefit of extreme difference of wettability of the patterned 
hydrophilic-superhydrophobic surface of droplet-microarray. No pipetting was 
needed in the creation of droplets. Reagents were added into droplets parallelly 
through a sandwiching approach. No contamination between droplets was observed. 
The influence of reagents on growth of bacteria can be detected by microscope using 
a strain producing green fluorescence protein, or applying a staining method.  In 
addition, a visual examination of the turbidity of dried droplets can be used to 
evaluate the inhibition effects of reagents to bacteria growth. Droplet-microarray was 
successfully used to screen a small library containing 18 antibiotics to identify the 
drug resistance of P. aeruginosa PA49 isolated from the environment.  
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In the second project, the working flow of droplet microarray-based high throughput 
screening was optimized and validated. Multi-resistant Klebsiella pneumoniae was 
used as the target. A non-contact liquid dispenser was used to print compounds onto 
droplet-microarray first. Then bacteria suspension was printed onto droplet-
microarray and incubated with pre-printed compounds. With the help of liquid 
dispensers, the accuracy of the screening process could be ensured. More importantly, 
a colorimetric readout method using Cell Counting Kit 8 has been developed. By 
detecting the color of droplets after staining with Cell Counting Kit 8, compounds 
presenting positive results, which were colorless, can be easily selected by eyes. 
Using a cheap paper scanner, the whole droplet-microarray slide can be scanned in 
six minutes. Scan images enable quantitative evaluation of bacteria growth in 
droplets by the analysis of color depth of droplets with a MATLAB program. Three 
candidates of hits have been selected from screened 608 compounds. Further, 3,000 
synthesized compounds from the ComPlat library are going to be screened using the 
droplet microarray-based high throughput system to find hit compounds against K. 
pneumoniae. 
Table 1. Direct comparison between droplet-microarray and 384-well plates 
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Droplet-microarray was further applied to fabricate patterned liquid infused surfaces. 
To prepare patterned biofilms with different bacteria, a lubricant containing 
perfluoropolyether was used to create ‘slippery’ regions to resist attachment of 
bacteria by infusing the lubricant into superhydrophobic area of the patterned 
hydrophilic-superhydrophobic surface of droplet-microarray. Biofilm patterns down 
to 350 µm were achieved. Between the biofilm patterens, a connection structure, 
termed ‘biofilm bridges’ was observed. It was shown that this bridge formation was 
a ubiquitous structure on patterned liquid infused surfaces for different bacteria 
including P. aeruginosa, S. maltophilia, and S. aureus. P. aeruginosa PA49 presented 
the highest number of biofilm bridges on surfaces compared with P. aeruginosa PA 
30 and the other bacteria. By staining with 5-cyano-2,3-ditolyl tetrazolium chloride 
and 4',6-diamidino-2-phenylindole, it was observed that metabolic active bacteria 
were surrounded by the biofilm matrix in bridges.  With fluorescence in situ 
hybridization, organisms’ distribution in bridges of multi-species biofilms were 
presented. S. maltophilia and P. aeruginosa did not mix homogeneously but formed 
spatial segregation in biofilm bridges.  
In the following project, P. aeruginosa and E. coli were used to reveal the mechanism 
of bridge formation It was demonstrated that after incubation of patterned liquid 
infused surfaces with bacterial suspensions, bacteria covered both liquid infused 
borders and hydrophilic regions. However, on the liquid infused regions, bacteria 
were not able to attach to the surface. Biofilm bridges were formed during the 
removal of growth medium from the surface. The distance of liquid infused borders 
affected the bridge formation. Biofilm bridges were observed with the distance up to 
700 µm between 350 µm size patterns. By altering the geometry of patterns and 
distance between patterns, the number of bridges and distribution of bridges can be 
changed. Then this strategy was used to control the connective bridge structure on 
patterned liquid infused surfaces. It is shown that biofilm bridges formed networks 
along different directions.  
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Finally, the continuity of biofilm bridges was investigated. Rhodamine solution was 
added to hydrophilic spots, where biofilm attached. Then the spread of rhodamine 
through the bridges was observed with the fluorescence microscope. Due to the 
hydrophilicity of biofilm bridges and the hydrophobicity of the liquid infused regions, 
aqueous dye solution was restrained in bridges. Rhodamine solution was able to reach 
neighboring hydrophilic spots in a few minutes. Next, it was shown that Mueller-
Hinton medium, which supports growth of bacteria, and polymyxin B solution, which 
is able to kill P. aeruginosa, can be transferred through biofilm bridges respectively 
and influence the viability of bacteria. The control of distribution of biofilms on 
surfaces provides great opportunity to study the transfer dynamics of pharmaceuticals 
in biofilms, biofilm formation and spreading mechanism, and signal exchange 
between different biofilm colonies, etc. 
The present study lays the groundwork for future research into droplet microarray-
based high throughput in microbiology. As far as I concerned, that the following 
points should be explored in future:  
1) The target of screening could be altered.  
Up to now, the high throughput screenings with droplet-microarray use 
planktonic bacteria as targets. The compounds able to inhibit the growth of 
planktonic bacteria are screened.  No anti-biofilm assay was established on 
droplet-microarray. Anti-biofilm compounds would be clinically relevant 
since biofilms are a major cause of persistent infections, and they are difficult 
to eliminate in patients. The study on biofilm bridges is helpful to prepare 
miniaturized biofilms on droplet-microarray. Corresponding characterization 
methods of biofilms on DMA should be established, e.g., colorimetric 
methods, fluorescence staining methods, MALDI-ToF measurements, PCR 
and sequencing, etc. 
2) Detailed and fundamental knowledge of ‘bacteria in droplets’ and ‘biofilms in 
droplets’ should be studied.  
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Although it has been demonstrated that droplet-microarray could be used in 
antibacterial screening, it is still not clear, e.g., the effect of small volume on 
biofilm formation, the formation of floating biofilms on liquid-air interfaces 
of droplets, the absorption of substances by the substrate of droplet-microarray, 
the dissolving process of compounds from surfaces into droplets, etc. That 
information is significant for future applications of droplet-microarray in 
antibacterial assays. 
3) Droplet-microarray could be used to investigate synergistic effects between drugs 
against multidrug resistant bacteria, which is a promising direction to find new 
therapies for infections from existing drugs. Then an efficient and accurate data 








5 Experimental Section 
5.1 Materials and Instruments 
Patterned superhydrophobic-hydrophilic glass slides (7.5 × 2.5 cm) were obtained 
from Aquarray GmbH (Eggenstein–Leopoldshafen, Germany). Ethanol, potassium 
phosphate, (NH4)2SO4, MgSO4, FeSO4, NaOH, HCl and glucose were from Merck 
(Darmstadt, Germany). Müller–Hinton (MH) medium was purchased from Merck 
(Darmstadt, Germany). Glass slides (Nexterion Glass B) were purchased from Schott 
(Jena, Germany). (1H, 1H, 2H, 2H-perfluorooctyl) silane was purchased from Sigma-
Aldrich (Munich, Germany). 5-Cyano-2,3-ditolyl-tetrazolium chloride (CTC) was 
purchased from Polysciences Europe GmbH (Hirschberg an der Bergstrasse, 
Germany). Ciprofloxacin was purchased from Fluka (Seelze, Germany). Ceftazidime 
and tazobactam were purchased from ACROS ORGANICS (Geel, Belgium). 
Tobramycin, cefotaxime, amoxicillin, ampicillin, polymyxin B, methicillin, colistin 
sulfate, ceftazidime, erythromycin, kanamycin sulfate, sulfamethoxazole and 
tetracycline were purchased from Sigma-Aldrich (Munich, Germany). Piperacillin 
was purchased from Alfa Aesar (Kandel, Germany). Imipenem and meropenem were 
purchased from Cayman Chemical Company (Michigan, USA). Chloramphenicol 
was purchased from AppliChem (Darmstadt, Germany). Streptomycin was 
purchased from Carl Roth (Karlsruhe, Germany). 4′,6-diamidino-2′-phenylindole 
dihydrochloride (DAPI) was from Sigma-Aldrich (Germany). Brain Heart Infusion 
(BHI) medium was purchased from Merck (Darmstadt, Germany). DNase was 
purchased from Peqlab (Erlangen, Germany). For Fluorescent In Situ Hybridization 
(FISH), we utilized 16S rRNA-targeted oligonucleotide probe Stemal (purchased 
from Eurofins) for S. maltophilia. The probe was labeled with ATTO550 at the 
sequence (5’-3’) of the probe sequence (GTCGTCCAGTATCCACTGC). For P. 
aeruginosa, we utilized 16S rRNA-targeted oligonucleotide probe PseaerB 
(purchased from Eurofins). The probe was labeled with AT488 at the sequence (5’-




Carboxylate-Modified Microspheres, 1.0 µm, red fluorescent (580/605), 2% solids 
were purchased from ThermoFisher Scientific (Germany). Krytox GPL 103 (Dupont 
KrytoxR GPL 103) was purchased from H Costenoble GmbH & Co. KG (Eschborn, 
Germany). Cell Counting Kit-8 was purchased from MedChemExpress (New Jersey, 
USA). 
The AxioImage M2 system equipped with an Apotome (Carl Zeiss, Oberkochen, 
Germany) was used for fluorescence microscopy. A DSA 25 contact angle 
goniometer (Krüss, Hamburg, Germany) was used for water contact angle 
measurement. The I-DOT non-contact liquid dispenser was purchased from 
Dispendix (Stuttgart, Germany). LEO 1530 Gemini scanning electron microscope 
(Zeiss, Jena, Germany) was used to take images of the substrate of patterned LIS. 
CanoScan 8800F was used to scan DMA slides. Non-contact liquid dispenser 
SciFlexarrayer S11 (Scienion AG, Germany) and I-DOT (CELLINK, Stuttgart, 
Germany) were used to print compounds on DMA. Non-contact liquid dispenser 





5.2 Experimental Procedures to Chapter 3.1 
Bacterial strain, medium preparation, and culture conditions 
Pseudomonas aeruginosa strain PAO1 was used as a screening target in this study. 
[200] This strain was tagged by introducing plasmid pUCP20::GFP by 
electroporation, resulting in the production of the green fluorescent protein (GFP) to 
facilitate monitoring of P. aeruginosa PAO1 pUCP20::GFP (designated P. 
aeruginosa PAO1 GFP) by fluorescence microscopy.  P. aeruginosa PAO1 GFP was 
routinely grown in Müller–Hinton (MH) broth medium overnight at 37°C. The 
bacterial suspension was adjusted to OD600 = 0.1 with minimal medium Basal 
Medium 2 (BM2) and then diluted 1:100 with BM2 medium to obtain a bacterial 
suspension of 106 colony forming units CFU mL-1. Pseudomonas aeruginosa strain 
PA49 (designated P. aeruginosa PA49) was cultured in BM2 medium overnight at 
37°C. The bacterial suspension was adjusted to OD600 = 0.1 with BM2 and then 
diluted 1:100 with BM2 medium to obtain a bacterial suspension of 106 CFU mL-1. 
Seeding and culture of bacteria on the DMA slide 
1.5 mL of solution was added to one of the three compartments of squares on the 
DMA slide ensuring that all 196 spots were covered. The droplet was left to stand for 
30 s to allow the bacteria to settle. The slide was then quickly tilted and the droplets 
(approximately 90 nL) containing an estimated 90-900 bacteria formed 
spontaneously as the liquid flowed away. 
For incubating bacterial cells, the DMA slide was placed inside a Petri dish within a 
box with wetted tissues that was closed to prevent evaporation. The box was placed 
in an incubator at 37°C and the bacteria were cultured for the required period. 
To calculate the volume of droplets on the DMA, we first prepared droplets on DMA 
slides. The height (H), contact angel (θ) and radius (r) of droplets were measured with 




of the droplets was then calculated based on the assumption that the droplets formed 
part of a spherical cap. 
To enumerate the bacteria on DMA slides, one of the three compartments in the DMA 
slide, which contained 196 bacterial droplets on its surface, was immersed into 20 
mL BM2 medium and vortexed for 60 s. The suspension was then serially diluted 
with cell wash buffer and 10 μl of the dilutions were seeded on Luria broth (LB) agar 
plates. After incubation for 24 h at 37°C, the colony number on LB agar plates was 
recorded and used to estimate the number of bacteria on the DMA slide. Details of 
the estimation are shown in the supporting information. 
Printing of antibiotics onto fluorinated glass slides 
Glass slides were cleaned by immersion in 1 M NaOH solution for 1 h, washed with 
water for 30 s, and then immersed in 1 M HCl for 30 min. After washing with water 
for 30 s, the cleaned glass slides were fluorinated by incubation overnight with 30 µL 
trichloro (1H, 1H, 2H, 2H-perfluorooctyl) silane in a pressurized (50 mbar) 
desiccator. Antibiotics were printed onto the slides using the I-Dot non-contact liquid 
dispenser. The antibiotics ceftazidime, tobramycin, ampicillin, vancomycin, 
tetracycline, piperacillin, erythromycin, amoxicillin, and carbenicillin were dissolved 
in DMSO (2 mg mL-1) whereas ciprofloxacin, polymyxin B, imipenem, and 
meropenem were dissolved in sterile water (2 mg mL-1). Further dilutions were 
performed with sterile water to obtain the appropriate amount of antibiotics per 
square with a printable volume ranging between 5 nL and 100 nL. After printing with 
antibiotics, the fluorinated glass slides were dried in air to remove traces of DMSO. 
Sandwiching DMA with preprinted antibiotics 
To expose the bacteria to antibiotics, an antibiotic pre printed slide was sandwiched 
with the DMA slide using the CellScreenChip (CSC, as described in Figure S1). This 
novel instrument allows the precise alignment of two glass slides while controlling 
the distance between them. The DMA slide and the antibiotic printed slide were 




between the two frames was controlled by four micro-screws, fixed at a specific 
height. This distance was adjusted depending on the height of the droplets, which is 
influenced by the size of the microarray pattern. The CSC was closed and aligned by 
four pillars located at the corners of the lower frame that are positioned to align with 
four reference holes in the upper frame. In this way, the bacteria-containing droplets 
on the DMA slide were placed in contact with the antibiotic imprinted slide without 
excess pressure. Since the antibiotics are printed in a specific pattern correlating to 
the DMA slide, the mirror image of the printed pattern was observed on the DMA 
slide after sandwiching. Sandwiching was carried immediately after the bacteria were 
seeded and to prevent evaporation, the sandwiched slides were placed in a humidified 
chamber during the stamping process. All experiments were conducted at 37°C with 
a stamping time of 20 min. 
Bacteria staining 
Using the I-Dot non-contact liquid dispenser, 5-cyano-2,3-ditolyl-tetrazolium 
chloride (CTC) solution (4 mM freshly prepared in medium) was printed onto a 
fluorinated glass slide (90 nL per spot). The CTC-stained slides were dried overnight 
and then exposed to bacteria using the same method used to transfer antibiotics; the 
stamping time was 10 min. After the addition of CTC, DMA slides loaded with 
bacteria-containing droplets were incubated for 3 h at 37°C.  
Imaging and analyzing growth of bacteria 
Before imaging, the DMA slide was dried for 10 min in the dark at room temperature 
to allow the bacteria to accumulate in a layer on the surface. Images of P. aeruginosa 
PAO1 GFP and CTC-stained P. aeruginosa PAO1 GFP were obtained manually with 
the Zeiss Axio Imager 2 microscope. To compare the fluorescence from bacteria in 
droplets on DMA slides and in 96-well plates, we transferred the bacteria suspension 
from the 96-well plate onto DMA slides to form droplets. After drying, squares on 




ImageJ was used for image analysis. The mean fluorescent intensity of hydrophilic 
squares (1,000  1,000 pixels per square) was measured. The mean intensity per pixel 
of the background was subtracted from this value to calculate the mean intensity 
produced by the GFP synthesized inside the bacteria. The background was detected 
on the superhydrophobic border within a square of 100  100 pixels. 
Time-kill assay of antibiotic on P. aeruginosa PAO1 on DMA surface 
To investigate the kinetics of antibiotic activity on DMA slides, we incubated 
suspensions of P. aeruginosa PAO1 (initial bacterial density OD600 = 1, 109 CFU mL-
1, BM2 medium) with polymyxin B (40 μg mL-1) for a predetermined time (5, 10, 15, 
30, 60, 120, 180, and 240 min) in a 96-well plate (100 mL) and on a DMA slide (90 
nL per droplet). To enumerate the bacteria on DMA slides, one of the three 
compartments in the DMA slide, which contained 196 bacterial droplets on its 
surface, was immersed into 20 mL BM2 medium and vortexed for 60 s. The 
suspension was then serially diluted with a cell wash buffer and 10 μL of the dilutions 
were seeded on Luria–Bertani broth (LB) agar plates. After incubation for 24 h at 
37°C, the colony number on LB agar plates was recorded and used to estimate the 
number of bacteria on the DMA slide. The number of bacteria per well in the 96-well 
plate was estimated in the same way following a culture of 17.6 μL of bacteria 
suspension. 
Screening of antibiotics on DMA surfaces with multi-drug resistant strain P. 
aeruginosa PA49 
Antibiotics (Table S2) were printed onto fluorinated glass slides using the I-Dot. The 
amount printed was calculated according to the MIC and the droplet volume (90 nL 
for 1 mm squares). P. aeruginosa PA49 suspension (106 CFU mL-1) was seeded onto 
DMA slides, which were then sandwiched with the antibiotic printed glass slides 
using the CSC instrument. The two surfaces were sandwiched at 37℃ for 20 min 
before the antibiotic printed glass slide was removed and the DMA surface was 




antibiotics added directly into bacterial solution (100 μL) to obtain the same 
concentration as that of the bacterial droplets on the DMA surface. The solutions 
were then incubated at 37°C for 24 h. After incubation the DMA surface was dried 
in air for 10 min. 
Statistical analysis 
All data were represented as mean ± SD of at least three individual repetitions for 




5.3 Experimental Procedures to Chapter 3.2 
Printing of compounds on DMA slides 
All compounds from the ComPlat library were dissolved in DMSO of concentration 
10 mM. 1.5 nL compound solution was printed onto individual hydrophilic spots by 
SciFlexarrayer S11. DMA printed with compounds were placed in a desiccator 
overnight at room temperature (~ 25 ℃). Then the slides were removed from the 
dessicator for bacteria printing. For experiments with antibiotics, antibiotics 
(ceftazidime pentahydrate, amoxicillin, and chloramphenicol) were firstly dissolved 
in DMSO of concentration 1 mg mL-1. Then solutions were diluted to proper 
concentration with DMSO for further printing. Colistin sulfate was dissolved in water 
of concentration of 1 mg mL-1 and then diluted for further printing. DMA printed 
with antibiotics were processed in the same way with DMA printed with testing 
compounds. 
Live/dead staining of bacteria 
Colonies of Klebsiella pneumoniae ATCC BAA-2146 were picked up from LB agar 
plates and inoculated into MH medium for overnight culture. 150 nL bacteria 
suspension of the overnight culture was printed on individual hydrophilic spots on 
DMA slides. Then 10 droplets were collected by pipetting to 0.1 mL MH medium 
and stained with 0.15 µL SYTO9 and 0.075 PI solution from the LIVE/DEAD™ 
BacLight™ Bacterial Viability Kit. After 15 min incubation in the dark at room 
temperature, stained bacteria suspension was removed to microscope slides and 
observed with epifluorescence microscope. Live/dead staining of initial bacteria 
suspension was processed in the same way as printed bacteria suspension. 
Colony counting tests of bacteria 
150 nL of bacteria suspension of determined density was printed on individual spots 
on DMA. Individual droplets of bacteria suspension on DMA were then removed by 




10 µL of prepared suspension was inoculated to MH agar plates and incubated 
statically at 37 ℃ for 18 h. Colony number of inoculated bacteria was counted, which 
was used to calculate the bacteria density in droplets. 
Printing of bacteria on DMA slides 
Colonies of Klebsiella pneumoniae were picked up from LB agar plates and 
inoculated into MH medium for overnight culture. The optical density of cultured 
bacteria suspension was measured. Bacteria suspension was diluted with MH 
medium to the calculated OD600 value = 0.001, corresponding to 1.2 ×106 CFU mL-
1. 150 nL prepared bacteria suspension was printed onto individual spots on DMA 
using liquid dispenser I.DOT MINI. Then DMA slides with compounds and bacteria 
were incubated statically at 37 ℃ for 18 h. To prevent evaporation, DMA slides were 
placed in a sealed box, with a piece of wet tissue inside to create high humidity.  
Colorimetric readout method using Kit8 
After incubation of DMA slides, 100 nL of Cell Counting Kit-8 solution was printed 
to individual droplets on DMA slides with I.DOT MINI. Then slides were incubated 
for another 1 h in the humidity box. Afterwards, DMA slides were placed into a paper 
scanner to scan the whole slide using the positive-film scan function. High resolution 
images (6400 dpi) were generated for next data analysis. 
Color depth of each droplet was analysed with MATLAB R2020b using a program 
provided by Prof. Markus Reischl. 
Statistical analysis 
All data is presented as mean ± SD. Experiments were at least repeated three times 





5.4 Experimental procedures to Chapter 3.3 
Preparation of pLIS 
Patterned superhydrophobic-hydrophilic glass slides were dipped into 70% ethanol 
for 10 min. After drying, the slides were dipped into DI water to form droplets in 
hydrophilic regions, which were separated by superhydrophobic regions without 
water. After that, a thin layer of Krytox GPL 103 was spread over the surface to cover 
the whole slides but only penetrate the hydrophobic regions. The extra Krytox liquid 
was removed by dipping the slides into water for 20 times and flushing with a stream 
of water for 30 s.  
Biofilm formation on pLIS 
Pseudomonas aeruginosa (PA30, PA49) isolated from environmental wastewater, 
Stenotrophomonas maltophilia DSM50170 (S. maltophilia) and Staphylococcus 
aureus DSM20231 (S. aureus) liquid cultures in Brain Heart Infusion (BHI) medium 
(1:4 water dilution) with optical density of 600 nm was 0.1 were prepared. To form 
biofilms, patterned LIS slides were immersed into bacterial suspension and incubated 
for determined times at 37 °C with 50 rpm shaking for a better nutrient distribution. 
In parallel biofilms were also cultivated under static conditions without shaking. 
Biofilm bridging did also occur under these conditions in a comparable way 
(Supporting Information). The medium was refreshed every 24 h. Slides were washed 
with buffer (5 × 10−3 M magnesium acetate, 10 × 10−3 M Tris-base, pH = 8) after 
incubation of defined periods of time. To stain with 5-cyano-2, 3-ditolyl-tetrazolium 
chloride (CTC) and 4′, 6-diamidino-2′-phenylindole dihydrochloride (DAPI), slides 
were firstly immersed into a CTC solution (4 mM freshly given to the medium) for 3 
h at 37 °C with 50 rpm shaking or without shaking, according to previous incubation 
condition. After that, the slides were put into DAPI solution (1 μg mL−1, water 
solution) and incubated for 10 min. Epifluorescence microscopy with AxioImage M2 
imaging system was applied to observe and take images of biofilms and bridges. To 




in the middle, and length of bridges in images were counted and measured with 
ImageJ software. At least 20 images for each sample were taken with the microscope 
and 5 samples for each bacterial species for statistics.  
For bacterial bridges analysis, 1000 folds magnification and Z-stacks were applied to 
obtain the images of stained biofilm bridges of P. aeruginosa PA49.  
To stain the biofilm bridges with 1 µm carboxylate-modified microspheres loaded 
with red dyes, the patterned LIS were incubated in BM2 medium with or without P. 
aeruginosa PA49 (optical density of 600 nm was 0.1) for 24 h at 37 °C. The samples 
were then stained with DAPI for 10 min as described above. After washing with DI 
water for three times, 10 mL of the solution of the microbeads (105 mL-1, water 
solution) was added to the sample, followed by 10 min incubation. The samples were 
taken out of the medium and imaged by epi-fluorescence microscopy. 
Formation of biofilm bridges of multiple species bacteria on pLIS and FISH staining 
Mixture suspension of P. aeruginosa PA49/S. maltophilia (DSM50170) (v/v = 1:1) 
and P. aeruginosa PA30/S. maltophilia (DSM50170) (v/v = 1:1) were prepared with 
initial concentration of each species suspension were all the same (OD600 = 0.1). LIS 
samples were incubated in bacteria suspension for 24 h with 50 rpm shaking at 37 ℃. 
Then samples were removed from the solution, washed, fixed, and treated with FISH 
hybridization buffer. The samples were fixed with 4% paraformaldehyde solution (in 
PBS buffer, pH = 7.4) for 1 h at room temperature. Then samples were immersed into 
lysozyme solution (70,000 U mL−1 in Tris-HCL pH = 7.5) for 10 min at 37 ℃. After 
the fixation and permeabilization, samples were adjusted in hybridization buffer with 
adequate formamide concentration (0.9 M NaCl, 20 mM Tris-HCL, pH = 7.5, 0.01% 
SDS, 30% formamide) for 10 min at 46 °C. Samples were immersed in 500 μL of the 
same solution previously mixed with FISH probes (purchased from Eurofins) for 1.5 
- 3 h at 46 °C. The concentration of probes was 6 ng oligonucleotide μL−1. Finally, 
the samples were immersed in a cell wash buffer for 10 min at 46 °C. After washing 




Quantification of biofilm occupation and bridges 
DAPI staining presenting DNA (biomass) in biofilm was quantified as biofilm 
occupation. Binary images were produced using ImageJ software and were inverted 
to make the biofilms show black or gray color. Then the threshold-adjusting option 
of ImageJ software was used to choose the biofilm occupation area (DAPI staining). 
To make sure all DAPI staining areas were chosen for further calculation; we adjusted 
the threshold to the level, which was able to include all pixels appearing gray or black 
(not white). Then the biofilm occupation is 
 𝒃𝒊𝒐𝒇𝒊𝒍𝒎 𝒐𝒄𝒄𝒖𝒑𝒂𝒕𝒊𝒐𝒏 (%) =
𝒂𝒓𝒆𝒂 𝒐𝒇 𝑫𝑨𝑷𝑰 𝒔𝒕𝒂𝒊𝒏𝒊𝒏𝒈 𝒊𝒏 𝒐𝒏𝒆 𝒉𝒚𝒅𝒓𝒐𝒑𝒉𝒊𝒍𝒊𝒄 𝒔𝒒𝒖𝒂𝒓𝒆
𝒕𝒐𝒕𝒂𝒍 𝒂𝒓𝒆𝒂 𝒐𝒇 𝒐𝒏𝒆 𝒉𝒚𝒅𝒓𝒐𝒑𝒉𝒊𝒍𝒊𝒄 𝒔𝒒𝒖𝒂𝒓𝒆
× 𝟏𝟎𝟎 %   
Number of bridges on LIS was visually counted with fluorescence images. Distance 
between two edges of the middle part of the bridge was calculated as the width of 
bridges with the distance measuring option of ImageJ software. Distance from one 
end to another end of bridges in hydrophilic spots was calculated as length of bridges 
with the distance measuring option of ImageJ software. At least 10 images were 
analyzed for each sample. 
Statistical analysis 
All data is presented as mean ± SD. Experiments were at least repeated twice 
individually using n ≥ 5 repetitions. All data was analyzed with two-sided Student’s 
t-test using OriginPro (OriginLab Corporation) software. Data with P-values <0.05 




5.5 Experimental procedures for Chapter 3.4 
Preparation of pLIS 
Patterned LIS was prepared as previously described. [2] Patterned superhydrophobic- 
hydrophilic glass slides were sterilized by dipping into 70% ethanol for 10 min. After 
drying in air, the slides were dipped into deionized water to form droplets in 
hydrophilic regions. A thin layer of Krytox GPL 103 was spread over the slides to 
cover the droplets of water in hydrophilic regions and infused into the hydrophobic 
regions. Then the extra Krytox lubricant was immediately removed by dipping the 
slides into water for 20 times and flushing with a stream of water for 30 s. 
Formation of bacterial bridges on pLIS 
Pseudomonas aeruginosa strain PA49 (P. aeruginosa PA49) isolated from 
environmental wastewater and Escherichia coli DSM 1116 (E. coli) were used in this 
study. [169] P. aeruginosa PA49 and E. coli were inoculated in Basal Medium 2 
(BM2; 62 × 10−3 M potassium phosphate, 7 × 10−3 M (NH4)2SO4, 2 × 10−3 M MgSO4, 
10 × 10−6 M FeSO4, and 0.4% glucose) separately and incubated at 37 °C with 
shaking (150 rpm) overnight. The overnight culture suspensions of two bacteria were 
then adjusted to optical density (OD) of 0.1 (≈1 × 107 bacteria per mL ) with BM2 
medium. Patterned LIS slides were immersed into bacterial suspension and incubated 
at 37 °C with 50 rpm shaking for 3 h. To show the metabolic activity of bacteria, 
CTC was added into BM2 medium (4 × 10−3 M) from the beginning of the incubation. 
Slides in the medium were observed with a microscope after incubation. Then the 
medium was removed with a pump set up (extraction speed: 2 mL min-1) to form 
bridges. Samples were observed with the microscope. To investigate the influence of 
glucose, BM2 medium without glucose (62 × 10−3 m potassium phosphate, 7 × 10−3 
M (NH4)2SO4, 2 × 10−3 M MgSO4, 10 × 10−6 M FeSO4) was used for incubation. To 
investigate the influence of bacterial density on bridge formation, overnight culture 
of P. aeruginosa PA49 was adjusted to (OD) of 0.01 (≈1 × 106 bacteria per mL) and 




formation, DNase (4 U mL−1) was added into the bacteria suspension from the 
beginning of the incubation. Bacteria suspension was then extracted after 3 h to form 
bridges. 
Rhodamine B, and antibacterial chemicals flowing through bridges 
Patterned LIS were incubated with P. aeruginosa PA49 suspension (≈1 × 107 
bacteria per mL, BM2 medium) at 37 °C with 50 rpm shaking for 3 h. Then the 
medium was removed to form bridges. 1 µL Rhodamine B water solution (2 mg mL-
1) was placed on the hydrophilic spots with grown biofilm. The flow of rhodamine 
solution was recorded with the epifluorescence microscope (Axioplane 2, Carl Zeiss, 
Oberkochen, Germany). To investigate the flow of Rhodamine B under lubricant, the 
surface including the formed bridges were covered with a layer of Krytox GPL 103 
again, with only one hydrophilic spot exposed to air. Then 1 µL rhodamine B water 
solution was placed on the hydrophilic spot with biofilm again. The flowing of 
rhodamine B from this hydrophilic spot to the other spots through bridges was 
recorded with a microscope. 
To investigate the transfer of nutrients and antibacterial chemicals through bridges. 
1 µL of BHI medium, water and polymyxin B (50 mg mL-1) was added in one spot 
respectively. The samples were placed in a box with high humidity and incubated for 
2 h. The number of living bacteria in the neighboring spots was counted with plate 
count method, which means 1 µL of bacteria suspension was aspirated from the spot, 
then the bacterial suspension was diluted to proper density. Diluted bacteria 
suspension was spread on LB agar plates and incubated overnight. Colony number 
on agar plates was counted and then the number of living bacteria in the initial spot 
was calculated.  
Statistical Analysis 
A two-sided Student’s t-test was used for statistical data evaluation. Experiments 




the experimental data was determined with a two‐tailed Student t ‐test (* p ‐value < 
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The water contact angle of DMA surfaces was analyzed with DSA 25 contact angle 
goniometer (Krüss, Germany) using the sessile drop technique. Advancing contact 
angles were obtained by measuring the angle while the liquid was slowly added at a 
rate of 0.1 mL s-1 from a ∼4 μL droplet to 14 μL in contact with the sample and a 
micrometer syringe. Receding contact angles were obtained with liquid slowly 
retracting at a rate of 0.1 mL s-1 from a ∼14 μL droplet to 4 μL. The data were 
represented as mean ± SD. For each kind of surface, the dynamic water contact angle 






Figure S1. (a) Distribution of the radius of droplets formed on DMA slides. (b) Distribution 
of the height of droplets formed on DMA slides. 61 droplets of BM2 medium formed on 
three DMA slides were randomly chosen and images of the droplets were obtained using 
DSA 25 contact angle goniometer (Krüss, Germany). Radius and height of the droplets were 
measured using ImageJ. 
 
Figure S2. (a) Distribution of bacteria number in individual droplets on DMA slides after 
the seeding of bacteria using the “standing droplet” method. Droplets of bacteria suspension 
(P. aeruginosa O1 GFP, 106 CFU mL-1) formed on DMA slides were collected separately 
with the pipette. The collected bacteria suspension was diluted with cell wash buffer and 
then inoculated on LB agar plates. Colony number on agar plates was counted after 
overnight incubation. Bacteria number in each droplet was calculated according to the 
colony number. Bacteria number in 45 droplets from 3 different DMA was counted (15 




slides placed in air and in the humidity box. BM2 medium was used to form droplets on 
DMA. DMA slides were placed in the open air at 24 ℃. The mass change of the total 588 
droplets on one DMA slide was measured with a microbalance at predetermined time points. 
To measure the mass change of droplets on DMA slides placed in humidity box, which was 
a sealed plastic box with a wet tissue in it at 24 ℃, the DMA slides were taken out from the 
box and measured the weight at predetermined time points.  
The mass of 588 droplets = 
The mass of the DMA slide with 588 droplets − The mass of the bare DMA slide 
The mass change of the droplets placed in humidity box at 37 ℃ over 24 h was 
measured as well. The total mass of the 588 droplets was decreased from 0.0671±






Figure S3. Scheme of workflow of sandwiching a DMA slide and an antibiotic preprinted 
slide using CellScreenChip (CSC). 1.1. Antibiotic printed slide is fixed in the upper frame 
of the CSC. 1.2. The DMA slide loaded with bacterial droplets on its surface is fixed in the 
lower frame of the CSC. 2. The upper frame is inverted and placed onto the lower frame of 
the CSC. 3. The CSC is closed, with the two frames aligned by four pillars and four micro-
screws that define the distance between the DMA slide and antibiotic pre-printed slide. 
The CellScreenChip (CSC) is a tool used to align two parallel glass slides. This 
instrument was designed in our laboratory and manufactured by Maschinenbau 
Kaltenbach GmbH (Crailsheim, Germany). It comprises two frames (upper and lower) 
that are manufactured to the same dimensions (127 mm  85 mm). Four pillars 
located at the corners of the lower frame are positioned to align with four reference 
holes in the upper frame in x and y direction. The upper frame contains four micro-
screws that define the distance between the parts. A clamp is embedded in each of 
the two frames, which have a notch that enables live observation of both glass slides 
while sandwiching using an automated screening microscope. The DMA slide 
containing the bacteria is fixed into the lower frame of the CSC, while the LMA slide 
pre-printed with antibiotics is fixed into the upper frame. The CSC is then closed and 
the micro-screws adjusted to fix the upper frame at a distance that allows contact 
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Figure S4. Relationship between OD value of bacteria suspensions and fluorescent intensity 
of the dried spots on the DMA slide. The OD values of dilutions of P. aeruginosa PAO1 
bacteria suspension were measured. These dilutions were then used to form droplets of 
bacteria suspension on the spots on DMA slides. The fluorescence intensity of the dried 
spots was measured using a fluorescence microscope. 
Estimation of bacterial density based on colony number on agar plates 
To enumerate the bacteria on DMA slides, one of the three compartments in the DMA 
slide, which contained 196 bacterial droplets on its surface, was immersed into 20 
mL BM2 medium and vortexed for 60 s. The suspension was then diluted with cell 
wash buffer (1:104) and 10 μL of the dilutions were seeded on LB agar plates. After 
incubation for 24 h at 37°C, the colony number on LB agar plates was recorded used 
to estimate the number of bacteria on the DMA slide. The bacterial number on the 
DMA slide was estimated using the following formula: 
Bacteria density (CFU mL-1) = 
𝐶𝑜𝑙𝑜𝑛𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 ×
20 mL
10−4  × 10 μL × 10−3  × 90 nL × 10−6 × 196 
 
 
Table S2. Colony number in agar plates. Bacteria were seeded as bacterial 







1.7 ± 0.5 
96-well plates 
1.5 ± 0.8 
Table S3. Antibiotic concentration printed on glass slides to test resistance of P. aeruginosa 
PA49 
Antibiotic MIC (mg L-1) Reference 









4 intrinsically resistant [1] 
chloramphenicol 
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Figure S5. Sensitivity of P. aeruginosa PA49 to polymyxin B and ceftazidime tested on 
DMA slides and in 96-well plates. Different amounts of polymyxin B and ceftazidime were 
printed on fluorinated glass slides and transferred into droplets of P. aeruginosa PA49 
suspension (BM2 medium, 106 CFU mL-1) using CSC. DMA slides were placed into a 
humidity box. For 96-well plates, antibiotics were added into wells containing 100 µL 
bacteria suspension. DMA slides were removed from the humidity box and dried in air after 
24 h incubation at 37 ℃. The antibiotic activity was evaluated by visual inspection of the 
transparency of the wells or droplets (opacity indicates live bacteria). The result was the 
readout from 10 spots of each concentration on DMA slides and 10 wells of each 
concentration in 96-well plates. Experiments were repeated twice. The antibiotic was 





6.2.2 Supporting Information of Chapter 3.2 
Figure S1. (a) Layout of compounds on one DMA slide. (b) Value of color depth of 
stained droplets incubated overnight on DMA printed with compounds from ComPlat 
as shown in (a). 
 




6.2.3 Supporting information of Chapter 3.3 
 
Figure S1. SEM image of the substrate of patterned LIS without lubricant. The scale 
bar: 1 µm. 
Surfaces without lubricant were prepared. Prior to SEM measurements, samples were 
sputtered with a 10 nm gold layer using a Cressington 108 auto sputter coater. LEO 
1530 Gemini scanning electron microscope (Zeiss, Germany) was used to take 
images of the substrate of patterned LIS. The SEM image shows the porous structure 







Table S1 Water contact angle and sliding angle of different area on patterned LIS. 
 





























LIS area 100.3°± 1° 100.4°± 5° 95.5°± 2° 1.6°± 0.2° 
 
We measured the water contact angle and sliding angle with DSA 25 contact angle 
goniometer (Krüss, Germany) using the sessile drop technique. Advancing contact 
angles were obtained by measuring the angle while the liquid was slowly added at a 
rate of 0.1 mL s-1 from a ∼4 μL droplet to 14 μL in contact with the sample and a 
micrometer syringe. Receding contact angles were obtained with liquid slowly 
retracting at a rate of 0.1 mL s-1 from a ∼14 μL droplet to 4 μL. Sliding angles were 
measured by using the tilting option with the rate of 60° min-1. The table shows small 
sliding angles of the lubricant infused surfaces, while the advancing water contact 
angles and receding water contact angles of the surface were smaller than those of 
the hydrophobic area, indicating the hydrophobic surfaces turned into slippery 





Figure S2. Fluorescence microscope images of biofilms of P. aeruginosa PA49 on patterned 
LIS after 1 day incubation in BM2 medium under static condition (without shaking). 
Biofilms were stained with CTC for 3 h then with DAPI for 10 min before images were 
produced. Red color represents active bacteria from CTC staining and blue color represents 




Figure S3. Images of mixed species biofilm bridges after FISH staining (individual 
fluorescence channel). (a) A single biofilm bridge where red fluorescence is from S. 
maltophilia (top) and green fluorescence comes from P. aeruginosa PA49 (bottom). (b) 




S.maltopohilia (red fluorescence, top). Patterned LIS slides were incubated with the bacteria 




Figure S4. Images of mixed species biofilm bridges after FISH staining. (a) A single biofilm 
bridge where red fluorescence is from S. maltophilia and green fluorescence comes from P. 
aeruginosa PA 30. (b)(c)(d) Biofilm bridges of a mixed population of P. aeruginosa PA49 
(green fluorescence) and S. maltophilia (red fluorescence). Patterned LIS slides were 






Figure S5. Fluorescence microscope images of biofilm bridges of P. aeruginosa PA49 of 
different length on patterned LIS after 1 day incubation in BM2 medium. Biofilms were 
stained with CTC for 3 h then with DAPI for 10 min before images were produced. Red 
color represents active bacteria from CTC staining and blue color represents DNA (external 
+ inside of bacteria). The microscope observations were completed by ImageJ software. The 




6.2.4 Supporting Information of Chapter 3.4 
 
Figure S1. (a)(b)(c) Fluorescence images of P. aeruginosa PA49 incubated with pLIS after 
3 h. Images were taken before the medium was removed. (d)(e)(f) Bright field images of P. 
aeruginosa PA49 incubated with patterned lubricant infused surfaces after 3 h. Images were 
taken before the medium was removed. 
 
Figure S2. (a) Fluorescence images showing breaking of a bacterial bridge of P. aeruginosa 
PA49 using a needle after the bacterial suspension was aspirated. A needle touched the 
bridge before the third second, then due to the touch of the needle, the bridge moved in the 
direction showing with the white arrow. Then the bridge was cut off by the needle. Part of 




hydrophilic bacteria attached area. The video shows that the ends of the bridge were attached 
to the hydrophilic area, while the bridge was not attached to the lubricant infused area. The 
video S2 is available as supporting information. (b) Fluorescence images showing breaking 
of a bridge of P. aeruginosa PA49. The pLIS slide was incubated in P. aeruginosa PA49 
suspension for 3 h. Then the bacterial bridge was formed by aspirating the liquid. After the 
incubation of the bridge in air for 24 h, it was broken by a needle. The video S3 is available 





1 2 3 4 5 6 7 8 9 10 
Height 
(µm) 
10.4 12.7 6.8 7.6 11.5 9.7 9.0 11.4 12.0 9.3 
Table S1. Height of the LIS borders. The pLIS (side length of hydrophilic square: 1 mm. 
Width of lubricant infused borders: 500 µm) slide was incubated with P. aeruginosa PA49 
in BM2 medium for 3 h. Then the slide was observed using bright field view of a microscope. 
Since the focusing plane of bacteria precipitated on the LIS borders and the bacteria attached 
to the hydrophilic area is different, we could use the difference of the focusing plane to 





Figure S3. (a) Bacteria number of the bacteria suspension before 3 h incubation, the 
supernatant of bacterial suspension after 3 h incubation and fully mixed bacterial suspension 
after 3 h incubation. Data were presented as mean ± SD of three experiments with three 
repeats each time. (b) Fluorescence image of patterned lubricant infused surface incubated 
vertically in bacterial suspension of P. aeruginosa PA49. CTC was added into bacterial 
suspension from the beginning of the incubation. 
 
 
Figure S4. (a) Number of bridges of P. aeruginosa PA49 on surfaces under different 
incubation conditions. PLIS (side length of hydrophilic square: 350 µm. Width of lubricant 
infused borders: 200 µm) were incubated with P. aeruginosa PA49 in BM2 medium, BM2 
medium without glucose, BM2 medium with DNase and BM2 medium with lower density 
of bacteria (low density 106 bacteria per mL vs. normal density of bacteria 107 bacteria per 
mL during the seeding step) for 3 h. The number of bridges was counted visually after the 




repeats each time. (b) Bright field image of P. aeruginosa PA49 on pLIS after 3 h incubation 
in BM2 medium. (c) Bright field image of P. aeruginosa PA49 on pLIS after 3 h incubation 
in BM2 medium without glucose. (d) Bright field image of P. aeruginosa PA49 of low 




Figure S5. Distribution of width of bacterial bridges. PLIS (side length of hydrophilic 
square:1 mm. Distance of lubricant infused borders: 500 µm) were incubated with P. 
aeruginosa PA49 in BM2 medium for 3 h. The width of bacterial bridges was measured 
using ImageJ with images of the bridges after the liquid was removed from the surfaces. 12 
bridges were randomly selected from three surfaces to measure the width, and the 





6.3 List of Abbreviations 
MIC Minimum inhibitory concentration 
ATP Adenosine triphosphate 
FDA U.S. Food and Drug Administration 
P. aeruginosa Pseudomonas aeruginosa 
S. aureus Staphylococcus aureus 
E. coli Escherichia coli 
M. tuberculosis Mycobacterium tuberculosis 
PDMS Polydimethylsiloxane 
RNA Ribonucleic ccid 
MRSA Methicillin-resistant Staphylococcus aureus 
PEG Polyethylene glycol 
PCR Polymerase chain reaction 
MALDI-ToF Matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometer 
OD Optical density 
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